ES2345595B1 - HYDROPHILE ACRYLIC SYSTEMS OF ELEVATE REFRACTION INDEX FOR PREPARATION OF INTRAOCULAR LENSES. - Google Patents
HYDROPHILE ACRYLIC SYSTEMS OF ELEVATE REFRACTION INDEX FOR PREPARATION OF INTRAOCULAR LENSES. Download PDFInfo
- Publication number
- ES2345595B1 ES2345595B1 ES200900828A ES200900828A ES2345595B1 ES 2345595 B1 ES2345595 B1 ES 2345595B1 ES 200900828 A ES200900828 A ES 200900828A ES 200900828 A ES200900828 A ES 200900828A ES 2345595 B1 ES2345595 B1 ES 2345595B1
- Authority
- ES
- Spain
- Prior art keywords
- methacrylate
- composition according
- baselineskip
- monomers
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title abstract description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000000178 monomer Substances 0.000 claims description 87
- 239000000203 mixture Substances 0.000 claims description 65
- -1 methoxy, ethyl Chemical group 0.000 claims description 29
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 25
- ROSDSFDQCJNGOL-UHFFFAOYSA-O dimethylaminium Chemical compound C[NH2+]C ROSDSFDQCJNGOL-UHFFFAOYSA-O 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 20
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 11
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 125000001624 naphthyl group Chemical group 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- MAXHZPRKOPYOBS-UHFFFAOYSA-N 2-methylprop-2-enoic acid;hydrobromide Chemical compound Br.CC(=C)C(O)=O MAXHZPRKOPYOBS-UHFFFAOYSA-N 0.000 claims description 7
- NUXLDNTZFXDNBA-UHFFFAOYSA-N 6-bromo-2-methyl-4h-1,4-benzoxazin-3-one Chemical compound C1=C(Br)C=C2NC(=O)C(C)OC2=C1 NUXLDNTZFXDNBA-UHFFFAOYSA-N 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 150000005840 aryl radicals Chemical class 0.000 claims description 4
- 125000001725 pyrenyl group Chemical group 0.000 claims description 4
- 150000003254 radicals Chemical class 0.000 claims description 4
- CEXQWAAGPPNOQF-UHFFFAOYSA-N 2-phenoxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1=CC=CC=C1 CEXQWAAGPPNOQF-UHFFFAOYSA-N 0.000 claims description 3
- 239000006096 absorbing agent Substances 0.000 claims description 3
- 239000012965 benzophenone Substances 0.000 claims description 3
- 150000008366 benzophenones Chemical class 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 3
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 claims description 2
- 150000001450 anions Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 239000003999 initiator Substances 0.000 claims description 2
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 claims description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 claims 1
- 150000001565 benzotriazoles Chemical class 0.000 claims 1
- 239000003505 polymerization initiator Substances 0.000 claims 1
- 238000010526 radical polymerization reaction Methods 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 12
- 238000002513 implantation Methods 0.000 abstract description 7
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 230000036571 hydration Effects 0.000 description 14
- 238000006703 hydration reaction Methods 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 239000012299 nitrogen atmosphere Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- GFHFQMHRBGDUAI-UHFFFAOYSA-N CCOC(C(C)=C)=O.Br Chemical compound CCOC(C(C)=C)=O.Br GFHFQMHRBGDUAI-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 208000002177 Cataract Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 5
- 230000009477 glass transition Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 230000010065 bacterial adhesion Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- PYNOHHMFQYUSDD-UHFFFAOYSA-N 2-(1,3-benzothiazol-2-ylsulfanyl)ethanol Chemical compound C1=CC=C2SC(SCCO)=NC2=C1 PYNOHHMFQYUSDD-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 125000003354 benzotriazolyl group Chemical class N1N=NC2=C1C=CC=C2* 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 239000007870 radical polymerization initiator Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- PLFFHJWXOGYWPR-HEDMGYOXSA-N (4r)-4-[(3r,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]pentan-1-ol Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1[C@@H](CCCO)C PLFFHJWXOGYWPR-HEDMGYOXSA-N 0.000 description 1
- JGTNAGYHADQMCM-UHFFFAOYSA-M 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-M 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- QGVNJBPLNRZKOX-UHFFFAOYSA-N 2,5-bis(ethenyl)pyrazine Chemical compound C=CC1=CN=C(C=C)C=N1 QGVNJBPLNRZKOX-UHFFFAOYSA-N 0.000 description 1
- RUHJZSZTSCSTCC-UHFFFAOYSA-N 2-(bromomethyl)naphthalene Chemical compound C1=CC=CC2=CC(CBr)=CC=C21 RUHJZSZTSCSTCC-UHFFFAOYSA-N 0.000 description 1
- DCGCLEMUTBJKCR-UHFFFAOYSA-N 2-(bromomethyl)pyrene Chemical compound C1=CC=C2C=CC3=CC(CBr)=CC4=CC=C1C2=C43 DCGCLEMUTBJKCR-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical group OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- YHXHHGDUANVQHE-UHFFFAOYSA-N 2-bromo-1-naphthalen-2-ylethanone Chemical compound C1=CC=CC2=CC(C(=O)CBr)=CC=C21 YHXHHGDUANVQHE-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ZMRFRBHYXOQLDK-UHFFFAOYSA-N 2-phenylethanethiol Chemical compound SCCC1=CC=CC=C1 ZMRFRBHYXOQLDK-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- DPZYLEIWHTWHCU-UHFFFAOYSA-N 3-ethenylpyridine Chemical compound C=CC1=CC=CN=C1 DPZYLEIWHTWHCU-UHFFFAOYSA-N 0.000 description 1
- PFYHKVQTYNQKQY-UHFFFAOYSA-N 4,6-bis(ethenyl)pyrimidine Chemical compound C=CC1=CC(C=C)=NC=N1 PFYHKVQTYNQKQY-UHFFFAOYSA-N 0.000 description 1
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 1
- XFOFBPRPOAWWPA-UHFFFAOYSA-N 6-hydroxyhexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCO XFOFBPRPOAWWPA-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- JFZHPFOXAAIUMB-UHFFFAOYSA-N Phenylethylmalonamide Chemical compound CCC(C(N)=O)(C(N)=O)C1=CC=CC=C1 JFZHPFOXAAIUMB-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- JNHALLGRQUJJQG-UHFFFAOYSA-N ethanamine;2-methylprop-2-enoic acid Chemical class CC[NH3+].CC(=C)C([O-])=O JNHALLGRQUJJQG-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- GXHMMDRXHUIUMN-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O.CS(O)(=O)=O GXHMMDRXHUIUMN-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- SXMHECGYSOUMFN-UHFFFAOYSA-N n-benzyl-n-methylprop-2-enamide Chemical compound C=CC(=O)N(C)CC1=CC=CC=C1 SXMHECGYSOUMFN-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011417 postcuring Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
- C08F220/301—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety and one oxygen in the alcohol moiety
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Sistemas acrílicos hidrófilos de elevado índice de refracción para preparación de lentes intraoculares.High index hydrophilic acrylic systems of refraction for preparation of intraocular lenses.
La presente invención describe la preparación de sistemas acrílicos hidrófilos de alto índice de refracción y propiedades bactericidas para la fabricación de lentes intraoculares (LIO) flexibles que se pueden insertar a través de pequeñas incisiones. Las lentes intraoculares moldeadas a partir de estos materiales se pueden hacer más delgadas o reducir su diámetro con relación a las lentes intraoculares flexibles conocidas, permitiendo disminuir la incisión necesaria para la implantación de las mismas. Además, estos sistemas presentan propiedades antisépticas frente a cepas específicas del ambiente ocular.The present invention describes the preparation of high refractive acrylic hydrophilic systems and Bactericidal properties for the manufacture of intraocular lenses Flexible (IOL) that can be inserted through small incisions The intraocular lenses molded from these materials can be made thinner or reduced in diameter with relationship to known flexible intraocular lenses, allowing reduce the incision necessary for their implantation. In addition, these systems have antiseptic properties against specific strains of the eye environment.
Description
Sistemas acrílicos hidrófilos de elevado índice de refracción para preparación de lentes intraoculares.High index hydrophilic acrylic systems of refraction for preparation of intraocular lenses.
Esta presente invención se refiere a la preparación de sistemas acrílicos hidrófilos de alto índice de refracción adecuados para la fabricación de lentes intraoculares (LIO) flexibles que se utilizan en cirugía mínimamente invasiva para el tratamiento de cataratas.This present invention relates to the Preparation of hydrophilic acrylic systems of high index of refraction suitable for the manufacture of intraocular lenses Flexible (IOL) that are used in minimally invasive surgery to Cataract treatment.
La cirugía de cataratas consiste en la eliminación del cristalino cuando éste se vuelve parcialmente opaco o pierde flexibilidad con la edad y es una de las operaciones más comunes en los países desarrollados en personas mayores de 65 años, operación que habitualmente se combina con la implantación de lentes intraoculares (LIO). La implantación de la lente permite restablecer las capacidades refractivas del ojo.Cataract surgery consists of lens removal when it becomes partially opaque or loses flexibility with age and is one of the most common in developed countries in people over 65, operation that is usually combined with lens implantation intraocular (IOL). The implantation of the lens allows to restore the refractive abilities of the eye.
Actualmente el empleo de lentes blandas que puedan doblarse e implantarse a través de incisiones de 3.5 mm se puede decir que se encuentra generalizado debido a las ventajas que supone. Se han fabricado lentes de este tipo a partir de diferentes materiales entre los que cabe resaltar por su mayor repercusión, las lentes de silicona y las lentes acrílicas, y de estos dos tipos, las lentes acrílicas presentan algunas ventajas, ya que pueden doblarse de una forma más controlable que las de silicona, y debido al alto índice de refracción de los materiales acrílicos, las lentes pueden llegar a fabricarse con espesores más delgados. Así, en el mercado se pueden encontrar dos tipos de lentes acrílicas blandas. Aquellas que están formadas por materiales flexibles pero que presentan grados de hidratación inferiores al 1%, o bien aquellas que están formadas de hidrogeles de poli(metacrilato de 2-hidroxietilo) (PHEMA) con grados de hidratación alrededor del 20% en agua. Dentro del primer tipo, se han fabricado lentes en base a copolímeros de acrilato de 2-fenetilo - metacrilato de 2-fenetilo (PEA/PEMA) comercializadas con el nombre de Alcon Acrylsof®, o en base a copolímeros de acrilato de etilo - metacrilato de etilo - metacrilato de 2,2,2-trifluoretilo (EA/EMA/TFEMA) comercializadas con el nombre de Allergan Clariflex®, con índices de refracción de 1.55 y 1.47, respectivamente. Dentro del segundo tipo se encuentran las lentes de PHEMA que presentan un grado de hidratación alrededor del 38% y un índice de refracción de 1.41 (Alcon HydroSof®). Estas lentes se han modificado mediante introducción de otros monómeros acrílicos hidrófobos para aumentar el índice de refracción, y en algunos casos la flexibilidad. Así se han fabricado lentes de copolímeros de HEMA con metacrilato de metilo (HEMA/MMA) con un índice de refracción de 1.47 y grado de hidratación del 20% comercializadas con el nombre ORC MemoryLens®, y de copolímeros de HEMA con metacrilato de 6-hidroxihexilo (HEMA/HEXMA) con un índice de refracción de 1.47 y una hidratación del 18% (Storz Hydroview®).Currently the use of soft lenses that can be folded and implanted through 3.5 mm incisions You can say that it is widespread due to the advantages that supposed. Lenses of this type have been manufactured from different materials among which it should be noted for its greater impact, the silicone lenses and acrylic lenses, and of these two types, the Acrylic lenses have some advantages, since they can bend in a more controllable way than silicone, and due to the high refractive index of acrylic materials, the lenses can get to be manufactured with thinner thicknesses. So, in the market You can find two types of soft acrylic lenses. Those that are formed by flexible materials but that present degrees of hydration below 1%, or those that are formed of poly (methacrylate) hydrogels 2-hydroxyethyl) (PHEMA) with degrees of hydration About 20% in water. Within the first type, they have been manufactured lenses based on acrylate copolymers of 2-phenethyl - methacrylate 2-phenethyl (PEA / PEMA) marketed under the name of Alcon Acrylsof®, or based on copolymers of ethyl acrylate - ethyl methacrylate - methacrylate 2,2,2-Trifluoroethyl (EA / EMA / TFEMA) marketed with the name of Allergan Clariflex®, with refractive indices of 1.55 and 1.47, respectively. Within the second type are PHEMA lenses that have a degree of hydration around of 38% and a refractive index of 1.41 (Alcon HydroSof®). These lenses have been modified by introducing other monomers hydrophobic acrylics to increase the refractive index, and in Some cases flexibility. This is how lenses of copolymers of HEMA with methyl methacrylate (HEMA / MMA) with a refractive index of 1.47 and degree of hydration of 20% marketed under the name ORC MemoryLens®, and copolymers of HEMA with 6-hydroxyhexyl methacrylate (HEMA / HEXMA) with a refractive index of 1.47 and a hydration of 18% (Storz Hydroview®).
Diversos materiales para preparación de lentes intraoculares que intentan llegar a un compromiso entre el grado de hidratación y el índice de refracción se han desarrollado en los últimos años bien mediante la introducción de monómeros hidrófobos o bien mediante la introducción de monómeros hidrófilos, y algunos de estos materiales se encuentran patentados. Comonómeros hidrófobos de alto índice de refracción que se han utilizado en la preparación de lentes intraoculares son metacrilatos con grupos aromáticos (Patente estadounidense US5693095) que dan lugar a copolímeros con un índíce de refracción de 1.53 en estado hidratado o metacrilatos con grupos etenilaromáticos (Patente estadounidense US 2007010883) que dan lugar a copolímeros con un índice de refracción de 1.52 a 1.55 una vez hidratado. También se han empleado comonómeros hidrófobos aromáticos derivados de anilina, bencilamina, fenol, fenilmetanol, feniletanol, naftol, bencilmercaptano y feniletilmercaptano (Patente estadounidense US2002037984) que dan lugar a copolímeros con un índice de refracción de 1.46 a 1.52 en estado seco, así como comonómeros hidrófobos derivados del fenol y del tiofenol (WO2007062864) y los derivados del fenoxietanol y del tiofenoxietanol (WO2007094664). Comonómeros hidrófilos de alto índice de refracción que se han utilizado en la preparación de lentes intraoculares blandas son los derivados del feniletanol funcionalizado en la posición para del anillo aromático (WO2006130402), los derivados de N-bencil-N-metilacrilamida (Patente estadounidense US 5717049) que dan lugar a copolímeros que tienen un índice de refracción de 1.42 a 1.49 en estado hidratado. En la patente estadounidense US5480950 se describe la utilización de comonómeros hidrófilos de N-vinilpirrolidona y 2, 3, o 4-vinilpiridina junto con ésteres diacrílicos, que dan lugar a copolímeros que tienen un índice de refracción de 1.42 a 1.49 en estado hidratado, y en la patente estadounidense US5439950 se describe la utilización de comonómeros vinílicos hidrófilos de heterociclos tales como 4,6-divinilpirimidina, 2,5-divinilpirazina, 1.4 y 1.5-divinilimidazol que dan copolímeros que tienen un índice de refracción de 1.40 a 1.60 en estado hidratado.Various materials for the preparation of intraocular lenses that attempt to reach a compromise between the degree of hydration and the refractive index have developed in recent years either by introducing hydrophobic monomers or by introducing hydrophilic monomers, and some of these Materials are patented. Hydrophobic comonomers of high refractive index that have been used in the preparation of intraocular lenses are methacrylates with aromatic groups (US Patent US5693095) that give rise to copolymers with a refractive index of 1.53 in the hydrated state or methacrylates with ethenylaromatic groups (US Patent US 2007010883) which give rise to copolymers with a refractive index of 1.52 to 1.55 once hydrated. Aromatic hydrophobic comonomers derived from aniline, benzylamine, phenol, phenylmethanol, phenylethanol, naphthol, benzylmercaptane and phenylethylmercaptan (US Pat. No. US2002037984) have also been used which give copolymers with a refractive index of 1.46 to 1.52 in the dry state, as well as comonomers hydrophobes derived from phenol and thiophenol (WO2007062864) and those derived from phenoxyethanol and thiophenoxyethanol (WO2007094664). High refractive hydrophilic comonomers that have been used in the preparation of soft intraocular lenses are those derived from functionalized phenylethanol in the para position of the aromatic ring (WO2006130402), those derived from N- benzyl- N- methylacrylamide (US Patent US 5717049 ) which give rise to copolymers having a refractive index of 1.42 to 1.49 in the hydrated state. US5480950 describes the use of hydrophilic comonomers of N- vinylpyrrolidone and 2,3, or 4-vinylpyridine together with diacrylic esters, which give rise to copolymers having a refractive index of 1.42 to 1.49 in the hydrated state, and US 5439950 describes the use of hydrophilic vinyl comonomers of heterocycles such as 4,6-divinylpyrimidine, 2,5-divinylpyrazine, 1.4 and 1.5-divinylimidazole which give copolymers having a refractive index of 1.40 to 1.60 in the hydrated state. .
Por otra parte, la endoftalmitis post-quirúrgica sigue siendo una de las complicaciones más importantes de la cirugía de cataratas. La adhesión bacteriana que sigue a la implantación de la lente intraocular es una de sus principales causas. A la adhesión le sigue la proliferación bacteriana hasta ir formándose varias capas de microcolonias que constituyen la estructura básica del posterior biofilm. Una vez formado, el biofilm puede sobrevivir el ataque de antibióticos en concentraciones de cien o mil veces superiores a las que pueden soportar las bacterias aisladas de la misma especie de forma que, llegado a este estadio, la única forma de atacar la infección es extraer la lente infraocular infectada. Por tanto, prevenir la adhesión bacteriana se ha considerado como el primer paso que hay que dar para atacar las infecciones post-quirúrgicas. De las composiciones poliméricas descritas anteriormente para su uso como LIOs, ninguna de ellas presenta actividad bactericida. Con la finalidad de obtener composiciones con esta actividad se han llevado a cabo algunas modificaciones superficiales en LIOs comerciales para dotar a la superficie de la lente de propiedades bactericidas. Así se han modificado superficialmente LIOs de PMMA con heparina, comercializadas por Pharmacia Production B.V. que han demostrado eficacia en la disminución de la adhesión bacteriana post-implantación (cfr. A. M. A. El-Asrar et al., Intern Ophthalmol 21, 71-74, 1997). También se han modificado superficialmente materiales tipo hidrogel mediante unión electrostática de porfirinas a copolímeros de HEMA con ácido metacrílico o con metacrilato de 2-dietilamino etilo, con grupos colgantes aniónicos o catiónicos respectivamente (cfr. C. Brady, et al., J Phys Chem B 111, 527-534, 2007). Otros desarrollos han consistido en el recubrimiento de LIOs acrílicas con copolímeros de poli(2-metacriloiloxietil fosforil colina -co- n-butil metacrilato) que ha resultado efectivo en la inhibición de la adhesión tanto de bacterias como de fibroblastos (cfr. M. Shigeta et al., J Cataract Refract Surg 32, 859-866, 2006).On the other hand, post-surgical endophthalmitis remains one of the most important complications of cataract surgery. The bacterial adhesion that follows the implantation of the intraocular lens is one of its main causes. The adhesion is followed by bacterial proliferation until several layers of microcolonies are formed that constitute the basic structure of the subsequent biofilm . Once formed, the biofilm can survive the attack of antibiotics in concentrations of one hundred or a thousand times higher than those isolated by the same species can withstand so that, at this stage, the only way to attack the infection is to extract the infected infraocular lens. Therefore, preventing bacterial adhesion has been considered as the first step that must be taken to attack post-surgical infections. Of the polymer compositions described above for use as IOLs, none of them have bactericidal activity. In order to obtain compositions with this activity, some surface modifications have been carried out in commercial IOLs to give the surface of the lens bactericidal properties. Thus, PMMA IOLs with heparin have been superficially modified, marketed by Pharmacia Production BV that have demonstrated efficacy in reducing post-implantation bacterial adhesion (cf. AMA El-Asrar et al ., Intern Ophthalmol 21, 71-74, 1997 ). Hydrogel-like materials have also been superficially modified by electrostatic bonding of porphyrins to copolymers of HEMA with methacrylic acid or with 2-diethylamino ethyl methacrylate, with anionic or cationic pendant groups respectively (cf. C. Brady , et al ., J Phys Chem B 111, 527-534, 2007). Other developments have involved the coating of acrylic IOLs with copolymers of poly (2-methacryloxyethyl phosphoryl choline-co-n-butyl methacrylate) which has been effective in inhibiting the adhesion of both bacteria and fibroblasts (cf. M. Shigeta et al ., J Cataract Refract Surg 32, 859-866, 2006).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La presente invención proporciona la preparación de sistemas acrílicos hidrófilos de alto índice de refracción y propiedades bactericidas para la fabricación de lentes infraoculares flexibles que comprende principalmente un monómero o mezclas de monómeros acrílicos hidrófilos de alto índice de refracción que pertenecen a la familia de los haluros de metacrilatos de n-alquilamonio y uno o varios monómeros acrílicos hidrófilos de la familia de los acrilatos o metacrilatos de n-hidroxialquilo. Además puede comprender otros monómeros acrilatos o metacrilatos que modulen la flexibilidad y otros monómeros de metacrilatos portadores de grupos azol. Estos sistemas también pueden incluir una cierta cantidad de un agente de absorción UV, polimerizable o no, como benzofenonas sustituidas y benzotriazoles.The present invention provides the preparation of hydrophilic acrylic systems of high refractive index and Bactericidal properties for the manufacture of infraocular lenses flexible comprising mainly a monomer or mixtures of high refractive hydrophilic acrylic monomers that they belong to the methacrylate halide family of n-alkylammonium and one or more acrylic monomers hydrophilic acrylate or methacrylate family of n-hydroxyalkyl. You can also understand others acrylate or methacrylate monomers that modulate flexibility and other methacrylate monomers bearing azol groups. These systems can also include a certain amount of an agent of UV absorption, polymerizable or not, as substituted benzophenones and Benzotriazoles
La presente invención está relacionada con la preparación de sistemas acrílicos hidrófilos de alto índice de refracción y propiedades bactericidas para la fabricación de lentes infraoculares acrílicas flexibles.The present invention is related to the Preparation of hydrophilic acrylic systems of high index of refraction and bactericidal properties for lens manufacturing Flexible acrylic infraoculars.
Estos sistemas o composiciones poliméricas presentan las siguientes características:These polymeric systems or compositions they have the following characteristics:
1.- Su elevado índice de refracción hace que pueda disminuir el espesor o diámetro de las lentes intraoculares con relación a las lentes infraoculares acrílicas flexibles conocidas en el estado de la técnica, permitiendo, de esta manera, disminuir la incisión necesaria para la implantación de la misma.1.- Its high refractive index makes may decrease the thickness or diameter of intraocular lenses in relation to flexible acrylic infraocular lenses known in the state of the art, allowing, in this way, decrease the incision necessary for the implantation of the same.
2.- Los sistemas acrílicos derivados de haluros de metacrilatos de n-alquilamonio presentan propiedades bactericidas provenientes de la sal de amonio cuaternario, con actividad frente a cepas frecuentemente encontradas en la cavidad ocular.2.- Halide-derived acrylic systems of n-alkylammonium methacrylates present bactericidal properties from ammonium salt quaternary, with activity against strains frequently found in the eye socket
3.- Los sistemas acrílicos derivados de haluros de metacrilatos de n-alquilamonio actúan como filtros de luz UV.3.- Halide-derived acrylic systems of n-alkylammonium methacrylates act as UV light filters
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Así, un primer aspecto de la presente invención se refiere a una composición polimérica que consiste en un sistema acrílico hidrófilo de alto índice de refracción y carácter bactericida, en adelante composición de la invención, que comprende al menos un monómero de fórmula general (I) y que pertenecen a la familia de los haluros de acrilatos o metacrilatos de n-alquilamonio y al menos un monómero acrílico hidrófilo.Thus, a first aspect of the present invention refers to a polymeric composition consisting of a system hydrophilic acrylic with high refractive index and character bactericidal, hereinafter composition of the invention, comprising at least one monomer of general formula (I) and belonging to the acrylate or methacrylate halide family of n-alkylammonium and at least one acrylic monomer hydrophilic
Los monómeros de acrilatos o metacrilatos de n-alquilamonio utilizados en la presente invención pertenecen a la fórmula general (I):The acrylate or methacrylate monomers of n-alkylammonium used in the present invention They belong to the general formula (I):
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
donde:where:
- n es un valor de 1 a 12, preferiblemente n es un valor de 2, 3, 4, 5, ó 6, más preferiblemente n es 2;n is a value of 1 to 12, preferably n is a value of 2, 3, 4, 5, or 6, more preferably n is 2;
- X es un anión que se selecciona del grupo que comprende un halógeno o un sulfonato,X is an anion which is selected from the group comprising a halogen or a sulfonate,
- R_{1} es un hidrógeno o un grupo metilo;R_ {1} is a hydrogen or a methyl group;
- R_{2} y R_{3} son iguales o diferentes entre sí, y representan un radical alquilo (C_{1}-C_{3}).R2 and R 3 are the same or different from each other, and represent a radical (C 1 -C 3) alkyl.
- R_{4} es un radical arilo, sustituido o no sustituido, o un radical acetilo, sustituido o no sustituido.R_ {4} is a aryl radical, substituted or unsubstituted, or an acetyl radical, substituted or unsubstituted.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
El término "alquilo" se refiere, en la presente invención, a cadenas alifáticas, lineales o ramificadas, que tienen de 1 a 3 átomos de carbono, por ejemplo, metilo, etilo, n-propilo, i-propilo. Preferiblemente el grupo alquilo es un metilo.The term "alkyl" refers, in the present invention, to aliphatic, linear or branched chains, having 1 to 3 carbon atoms, for example, methyl, ethyl, n-propyl, i-propyl. Preferably the alkyl group is a methyl.
El término "arilo" se refiere en la presente invención a una cadena carbocíclica aromática, que tiene de 6 a 18 átomos de carbono, pudiendo ser de anillo único ó múltiple, en este último caso con anillos separados y/o condensados. Un ejemplo, no limitante, de arilo es un grupo fenilo, naftilo, antracenilo o pirenilo. Los radicales arilo pueden estar opcionalmente sustituidos por uno o más sustituyentes tales como halógeno, hidroxilo amino, amido, éster, acilo, éter, tiol, alcóxilo o tiol.The term "aryl" refers to the present invention to an aromatic carbocyclic chain, which has 6 to 18 carbon atoms, being able to be single or multiple ring, in the latter case with separate and / or condensed rings. A non-limiting example of aryl is a phenyl, naphthyl group, anthracenyl or pyrenyl. Aryl radicals can be optionally substituted by one or more substituents such as halogen, hydroxyl amino, amido, ester, acyl, ether, thiol, alkoxy or thiol.
El término "acilo" se refiere, en la presente invención, a un derivado de ácido carboxílico por eliminación de un grupo hidroxilo. Los derivados de ácido carboxílico tienen como fórmula general R^{5}-CO-, donde R^{5} es un grupo arilo con las acepciones anteriores, como por ejemplo, pero sin limitarse a fenilo, naftilo, antracenilo o pirenilo. Preferiblemente R^{5} es un grupo fenilo o naftilo.The term "acyl" refers, in the present invention, to a carboxylic acid derivative by elimination of a hydroxyl group. Acid derivatives carboxylic have as general formula R 5 -CO-, where R 5 is an aryl group with the above meanings, such as for example, but not limited to phenyl, naphthyl, anthracenyl or pyrenyl. Preferably R 5 is a phenyl or naphthyl group.
Por "halógeno" se entiende en la presente invención a un átomo de bromo, cloro, yodo o flúor. Preferiblemente el halógeno es bromo.By "halogen" is meant herein invention to a bromine, chlorine, iodine or fluorine atom. Preferably The halogen is bromine.
Por "sulfonato" se entiende en la presente invención a un ión que contiene el grupo funcional -SO_{3}^{-}. Su fórmula general es R^{6}SO_{3}^{-}, donde R^{6} se refiere a grupos alquilo (C_{1}-C_{6}) lineal o ramificado, arilo, sustituidos o no sustituidos. Ejemplos, no limitantes, de sulfonato son el ión mesilato (metanosulfonato) (MsO), el ión triflato (trifluorometanosulfonato) (TfO), el ión tosilato (p-toluenosulfonato) (TsO) o el ión nonafluorobutanosulfonato (ONf).By "sulphonate" is meant in the present invention an ion containing the functional group -SO 3 -. Its general formula is R 6 SO 3 -, where R 6 refers to linear or branched (C 1 -C 6) alkyl, aryl, substituted or unsubstituted groups . Non-limiting examples of sulfonate are the mesylate (methanesulfonate) ( MsO ) ion, the triflate (trifluoromethanesulfonate) ( TfO ) ion, the tosylate (p-toluenesulfonate) ( TsO ) ion or the nonafluorobutanesulfonate (ONf) ion.
Una realización preferida de la composición de la invención, comprende los monómeros de fórmula (I) seleccionados de la lista que comprende bromuro de metacrilato de 2-(N-bencil,N,N-dimetilamonio)etilo, metacrilato de 2-(N-metilennaftil,N,N-dimetilamonio)etilo, metacrilato de 2-(N-metilenpirenil,N,N-dimetilamonio)etilo, metacrilato de 2-(N-metilenacetofenil,N,N-dimetilamonio) etilo, metacrilato de 2-(N-metilenacetonaftil,N,N-dimetilamonio)etilo o cualquiera de sus combinaciones.A preferred embodiment of the composition of The invention comprises the monomers of formula (I) selected from the list comprising methacrylate bromide of 2- (N-benzyl, N, N-dimethylammonium) ethyl, methacrylate 2- (N-methylenenaphthyl, N, N-dimethylammonium) ethyl, methacrylate 2- (N-methylene pirenyl, N, N-dimethylammonium) ethyl, methacrylate 2- (N-Methylenacetophenyl, N, N-Dimethylammonium) ethyl methacrylate 2- (N-Methylenaketonephthyl, N, N-dimethylammonium) ethyl or any of its combinations.
En otra realización preferida de la composición de la invención, el monómero acrílico hidrófilo es un acrilato y/o metacrilato de n-hidroxialquilo, o cualquiera de sus combinaciones.In another preferred embodiment of the composition of the invention, the hydrophilic acrylic monomer is an acrylate and / or n-hydroxyalkyl methacrylate, or any of its combinations
Los monómeros hidrófilos acrilatos y/o metacrilatos de n-hidroxialquilo utilizados en la presente invención pertenecen a la fórmula general (II):Hydrophilic acrylate and / or monomers n-hydroxyalkyl methacrylates used in the Present invention belong to the general formula (II):
donde:where:
- n es un valor de 0 a 4, preferiblemente n es 2n is a value of 0 to 4, preferably n is 2
- m es un valor de 0 a 1, preferiblemente m es 0; ym is a value of 0 to 1, preferably m is 0; Y
- R_{1} es un hidrógeno o un grupo metilo.R_ {1} is a hydrogen or a methyl group.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
En una realización más preferida el monómero de fórmula (II) es el metacrilato de 2-hidroxietilo (HEMA).In a more preferred embodiment the monomer of formula (II) is 2-hydroxyethyl methacrylate (HEMA)
En otra realización preferida de la composición de la invención, además comprende al menos un monómero acrilato o metacrilato de fórmula general (III) que puede modular la flexibilidad de la composición final:In another preferred embodiment of the composition of the invention, further comprising at least one acrylate monomer or methacrylate of general formula (III) that can modulate the flexibility of the final composition:
donde:where:
- n es 1 ó 2,n is 1 or 2,
- R_{1} es un hidrógeno o un grupo metilo; yR_ {1} is a hydrogen or a methyl group; Y
- R_{2} se selecciona de la lista que comprende un hidrógeno, un alquilo (C_{1}-C_{6}), arilo o un alcoxilo.R2 is select from the list comprising a hydrogen, an alkyl (C 1 -C 6), aryl or an alkoxy.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
El término "alcoxilo" se refiere, en la presente invención, a un grupo de fórmula general R^{7}-O-, donde R^{7} es un grupo alquilo con las acepciones anteriores y preferiblemente se refiere a grupos alquilo (C_{1}-C_{6}), lineal o ramificado, o un grupo arilo con las acepciones anteriores. Como ejemplo de grupo alcoxilo, pero sin limitarse, son metoxi, etoxi, propoxi, butoxi, fenoxi o naftiloxi.The term "alkoxy" refers, in the present invention, to a group of general formula R 7 -O-, where R 7 is an alkyl group with the above meanings and preferably refers to groups (C 1 -C 6) alkyl, linear or branched, or a aryl group with the previous meanings. As a group example alkoxy, but not limited to, are methoxy, ethoxy, propoxy, butoxy, phenoxy or naphthyloxy.
En una realización preferida, R_{2} de la fórmula general (III) es un alquilo, seleccionado de la lista que comprende metilo, etilo, propilo o butilo.In a preferred embodiment, R2 of the general formula (III) is an alkyl, selected from the list that It comprises methyl, ethyl, propyl or butyl.
En otra realización preferida, R_{2} de la fórmula general (III) es un fenilo o naftilo.In another preferred embodiment, R2 of the General formula (III) is a phenyl or naphthyl.
En otra realización preferida de la composición de la invención, el monómero de fórmula (III) es el metacrilato de 2-etoxietilo, metacrilato de bencilo, metacrilato de 2-fenoxietilo o cualquiera de sus combinaciones.In another preferred embodiment of the composition of the invention, the monomer of formula (III) is methacrylate of 2-ethoxyethyl, benzyl methacrylate, methacrylate 2-phenoxyethyl or any combination thereof.
En otra realización preferida de la composición de la invención, además comprende al menos un monómero de metacrilato portador de grupos azol, de fórmula general (IV),In another preferred embodiment of the composition of the invention, further comprising at least one monomer of methacrylate carrier of azol groups, of general formula (IV),
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
donde:where:
n es un valor de 1 a 6, preferiblemente n es un valor de 1, 2, 3 o 4, más preferiblemente n es 2, es decir, el monómero de de fórmula (IV) es el metacrilato de (benzotiazoliltio)etilo.n is a value from 1 to 6, preferably n is a value of 1, 2, 3 or 4, more preferably n is 2, that is, the monomer of formula (IV) is methacrylate of (benzothiazolylthio) ethyl.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
En otra realización preferida de la composición de la invención, además comprende un agente de absorción de UV, que puede ser polimerizable o no, preferiblemente de la familia de benzofenonas sustituidas y benzotriazoles. Estos agentes de absorción UV son compuestos que absorben luz de una longitud de onda inferior a 400 nm. Este compuesto se incorpora a la mezcla de monómeros y queda atrapado en la matriz polimérica una vez que se ha producido la polimerización. Es preferible utilizar un compuesto que aparte de absorber la luz UV sea además polimerizable, de esta manera se evitará el riesgo de lixiviación del agente UV en el medio biológico a largo plazo.In another preferred embodiment of the composition of the invention, further comprising a UV absorbing agent, which it can be polymerizable or not, preferably of the family of substituted benzophenones and benzotriazoles. These agents of UV absorption are compounds that absorb light of a wavelength less than 400 nm. This compound is incorporated into the mixture of monomers and gets trapped in the polymer matrix once it has been polymerization occurred. It is preferable to use a compound that apart from absorbing UV light it is also polymerizable, of this way the risk of leaching of the UV agent in the medium will be avoided Long-term biological.
Un segundo aspecto de la presente invención se refiere a un procedimiento de obtención de la composición de la invención que comprende los siguientes pasos (a partir de ahora procedimiento de la invención):A second aspect of the present invention is refers to a procedure for obtaining the composition of the invention comprising the following steps (from now on method of the invention):
- i) i)
- consiste en mezclar los monómeros de fórmula general (I) con los monómeros de fórmula general (II) y opcionalmente, monómeros de fórmula general (III) y/o (IV) y/o agentes de absorción UV, con un iniciador de polimerización radical,consists of mixing the monomers of the general formula (I) with the monomers of general formula (II) and optionally, monomers of general formula (III) and / or (IV) and / or absorption agents UV, with a radical polymerization initiator,
- ii) ii)
- la mezcla de reacción del paso (i) se desoxigena,the reaction mixture from step (i) is deoxygenated,
- iii) iii)
- a continuación se somete a tratamiento térmico a una temperatura entre 45ºC y 70ºC, durante el tiempo necesario hasta alcanzar la conversión total, yit is then heat treated temperature between 45ºC and 70ºC, for the necessary time until achieve total conversion, and
- iv) iv)
- posteriormente el material se somete a un post-curado a una temperatura entre 60ºC y 80ºC durante un tiempo de entre 24 y 96 horas. El post curado es un tratamiento térmico a una temperatura superior a la de reacción con el fin de hacer reaccionar el monómero residual y eliminar algún resto de reacción.subsequently the material is subjected to a post-cure at a temperature between 60ºC and 80ºC for a time between 24 and 96 hours. The post cured is a heat treatment at a temperature higher than the reaction with in order to react the residual monomer and eliminate some rest of reaction.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
En una realización preferida del procedimiento de la invención, los compuestos que se mezclan en i) son uno o varios de los monómeros haluros de metacrilatos de n-alquilamonio de Fórmula (I) en una cantidad comprendida entre un 1-30%-p para maximizar el índice de refracción y poder bactericida, uno o varios monómeros hidrófilos acrílicos de fórmula (II) en una cantidad comprendida entre un 40-60%-p, uno o varios monómeros acrílicos de fórmula (III) en una cantidad comprendida entre un 5-20%-p, y opcionalmente, uno o varios monómeros portadores de grupos azol de fórmula (IV) en una cantidad comprendida entre un 1-30%-p y/o agentes de absorción UV en una proporción preferiblemente entre 0.1-5%-p (en peso de la composición final).In a preferred embodiment of the procedure of the invention, the compounds that are mixed in i) are one or several of the halide methacrylate monomers of n-alkylammonium of Formula (I) in an amount between 1-30% -p to maximize the refractive index and bactericidal power, one or more monomers acrylic hydrophilic of formula (II) in an amount comprised between 40-60% -p, one or more acrylic monomers of formula (III) in an amount between a 5-20% -p, and optionally, one or more monomers carriers of azol groups of formula (IV) in an amount between 1-30% -p and / or agents of UV absorption in a proportion preferably between 0.1-5% -p (by weight of the final composition).
En otra realización del procedimiento de la invención, el iniciador de polimerización radical es el azobisisobutironitrilo (AIBN) en una proporción entre 0.3 y 2% en peso de la composición.In another embodiment of the procedure of the invention, the radical polymerization initiator is the azobisisobutyronitrile (AIBN) in a proportion between 0.3 and 2% in composition weight.
En otra realización del procedimiento de la invención, la mezcla de reacción del paso (ii) se desoxigena con corriente de nitrógeno.In another embodiment of the procedure of the invention, the reaction mixture of step (ii) is deoxygenated with nitrogen stream
En otra realización preferida del procedimiento
de la invención, la mezcla del paso (ii) se somete a tratamiento
térmico de 50-70ºC durante 16-24
horas y seguidamente a un post-curado a una
temperatura entre 60-80ºC durante
24 h.In another preferred embodiment of the process of the invention, the mixture of step (ii) is subjected to heat treatment of 50-70 ° C for 16-24 hours and then post-curing at a temperature between 60-80 ° C for
24 h
De esta forma, por adición de la mezcla de reacción del paso (ii) sobre moldes cilíndricos con posterior desmoldeo en el paso iv) del procedimiento de la invención, se pueden obtener pequeños cilindros o varillas. A partir de las varillas se pueden procesar numerosos discos que tienen cada uno un grosor de aproximadamente 4 mm. Aunque se pueden obtener discos de espesores comprendidos entre 0.5 y 4 mm dependiendo del volumen de reacción utilizado. Estos discos son adecuados para la fabricación de lentes intraoculares flexibles, para su implantación en el tratamiento de cataratas con cirugía mínimamente invasiva.In this way, by adding the mixture of reaction of step (ii) on cylindrical molds with subsequent demoulding in step iv) of the process of the invention, They can get small cylinders or rods. Starting at rods can be processed numerous discs that each have a thickness of approximately 4 mm. Although you can get disks from thicknesses between 0.5 and 4 mm depending on the volume of reaction used. These discs are suitable for manufacturing of flexible intraocular lenses, for implantation in the Cataract treatment with minimally invasive surgery.
Por tanto, un tercer aspecto de la presente invención se refiere al uso de la composición de la invención como sistemas acrílicos hidrófilos de elevado índice de refracción y propiedades bactericidas, para la fabricación de lentes flexibles intraoculares.Therefore, a third aspect of the present invention refers to the use of the composition of the invention as hydrophilic acrylic systems of high refractive index and bactericidal properties, for the manufacture of flexible lenses intraocular
A lo largo de la descripción y las reivindicaciones la palabra "comprende" y sus variantes no pretenden excluir otras características técnicas, aditivos, componentes o pasos. Para los expertos en la materia, otros objetos, ventajas y características de la invención se desprenderán en parte de la descripción y en parte de la práctica de la invención. Los siguientes ejemplos y figuras se proporcionan a modo de ilustración, y no se pretende que sean limitativos de la presente invención.Throughout the description and the claims the word "comprises" and its variants not they intend to exclude other technical characteristics, additives, components or steps. For those skilled in the art, other objects, advantages and features of the invention will be partly detached of the description and in part of the practice of the invention. The following examples and figures are provided by way of illustration, and are not intended to be limiting of the present invention.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Fig. 1. Muestra los espectros de absorción UV de los bromuros de los metacrilatos de etilamonio derivados de antracenilo, naftilo, acetonaftilo y pirenilo junto con el espectro del metacrilato portador del grupo benzotiazol.Fig. 1. Shows the UV absorption spectra of bromides of ethylammonium methacrylates derived from anthracenyl, naphthyl, acetonephthyl and pyrenyl together with the spectrum of the methacrylate carrier of the benzothiazole group.
Fig. 2. Muestra los resultados del ensayo MTT. *: Análisis estadístico respecto al TMX (p< 0.05). **: Análisis estadístico respecto al material HEMA/EEMA 80:20 (p< 0.05).Fig. 2. Shows the results of the MTT test. *: Statistical analysis with respect to TMX (p <0.05). **: Analysis statistical regarding the HEMA / EEMA 80:20 material (p <0.05).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los monómeros de fórmula general (I) se preparan mediante un proceso de alquilación del monómero metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) o el monómero metacrilato de 2-(N,N-dietilamino)etilo (DEAEMA) con el haluro del radical R_{2} correspondiente, en condiciones suaves. La preparación del monómero cuando R_{1} es un radical metilo y R_{2} es un radical arilo se describe en la publicación de Lu y col. (cfr. G. Lu, D, Wu, R. Fu., Reactive & Functional Polymers 67, 355-366, 2007). La preparación del monómero cuando R_{1} es un radical metilo y R_{2} es un radical naftilo o antracenilo se describe en la solicitud de patente europea EP0500321A1. La preparación del monómero cuando R_{1} es un radical metilo y R_{2} es un radical cetoarilo se prepara según se describe en la publicación de Sarker y col. (cfr. A. M. Sarker, et al., Macromolecules 32, 5203-5209, 1999). Este proceso es extensible al resto de monómeros recogidos en la Fórmula (I).The monomers of general formula (I) are prepared by an alkylation process of 2- (N, N-dimethylamino) ethyl methacrylate monomer (DMAEMA) or 2- (N, N-diethylamino) ethyl methacrylate monomer (DEAEMA) with the halide of the corresponding radical R2, under mild conditions. The preparation of the monomer when R 1 is a methyl radical and R 2 is an aryl radical is described in Lu et al. (cf. G. Lu, D, Wu, R. Fu., Reactive & Functional Polymers 67, 355-366, 2007). The preparation of the monomer when R 1 is a methyl radical and R 2 is a naphthyl or anthracenyl radical is described in European patent application EP0500321A1. The preparation of the monomer when R 1 is a methyl radical and R 2 is a ketoaryl radical is prepared as described in Sarker et al. (cf. AM Sarker, et al ., Macromolecules 32, 5203-5209, 1999). This process is extensible to the other monomers collected in Formula (I).
\newpage\ newpage
Síntesis del Bromuro de metacrilato de 2-(N-bencil,N,N-dimetil amonio)etilo (en adelante MON.BENCILO): Synthesis of 2- (N-benzyl, N, N-dimethyl ammonium) ethyl methacrylate bromide (hereinafter MON.BENCILO):
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se sintetizó como sigue:It was synthesized as follows:
i) se puso a disolver metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) en éter dietílico y trietilamina a 0ºC de temperatura,i) was dissolved to dissolve methacrylate of 2- (N, N-dimethylamino) ethyl (DMAEMA) in ether diethyl and triethylamine at 0 ° C temperature,
ii) en atmósfera de nitrógeno, se añadió gota a gota una cantidad estequiométrica de bromuro de bencilo, a la disolución de (i) y se dejó reaccionar durante 16 horas a temperatura ambiente en agitación, yii) under a nitrogen atmosphere, was added drop by drop a stoichiometric amount of benzyl bromide, to the solution of (i) and allowed to react for 16 hours at stirring room temperature, and
iii) se aisló por filtración obteniéndose un polvo blanco que se lavó con éter dietílico, se secó a vacío hasta pesada constate y se caracterizó por resonancia magnética nuclear de protón (^{1}H-RMN) y carbono (^{13}C-RMN). Rendimiento cuantitativo.iii) was isolated by filtration obtaining a white powder that was washed with diethyl ether, dried under vacuum until heavy constate and was characterized by nuclear magnetic resonance of proton (1 H-NMR) and carbon (13 C-NMR). Quantitative performance
^{1}H-RMN (300 MHz, D_{2}O,
45ºC) \delta (ppm): 7.84 (s, 5H, Ar), 6.42 (s, 1H,
COCH_{3}=CHaH), 6.04 (s, 1H, OCOCH_{3}=
CHbH), 4.96 (t, 2H, J = 4.4 Hz,
N^{+}CH_{2}), 4.87 (s, 2H, ArCH_{2}), 4.05 (t,
2H, J = 4.4 Hz, CO_{2}CH_{2}), 3.4 (s, 6H,
NMe_{2}). 2.20 (s, 3H, OCOCH_{3}).1 H-NMR (300 MHz, D 2 O, 45 ° C) δ (ppm): 7.84 (s, 5H, Ar ), 6.42 (s, 1H, COCH 3 = C Ha H), 6.04 (s, 1H, OCOCH_ {3} =
C Hb H), 4.96 (t, 2H, J = 4.4 Hz, N + C H 2 ), 4.87 (s, 2H, ArC H2 ), 4.05 (t, 2H, J = 4.4 Hz, CO 2 C H 2 ), 3.4 (s, 6H, N Me 2 ). 2.20 (s, 3H, OCOC H {3}).
^{13}C-RMN (75 MHz, D_{2}O, 45ºC) \delta (ppm): 169.1, 135.9, 133.7, 131.6, 129.9, 128.4, 127.5, 70.0, 63.3, 59.0, 51.0, 17.9.13 C-NMR (75 MHz, D 2 O, 45 ° C) δ (ppm): 169.1, 135.9, 133.7, 131.6, 129.9, 128.4, 127.5, 70.0, 63.3, 59.0, 51.0, 17.9.
Índice de refracción teórico, n_{D}^{20} = 1.517.Theoretical refractive index, n_ {D} 20 = 1,517.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Síntesis del bromuro de metacrilato de 2-(N-metilennaftil,N,N-dimetilamonio) etilo (en adelante MON.NAFTILO): Synthesis of 2- (N-methylenenaphthyl, N, N-dimethylammonium) ethyl methacrylate bromide (hereinafter MON.NAFTILO):
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La síntesis del monómero MON.NAFTILO comprende las siguientes etapas:The synthesis of the MON.NAFTILO monomer comprises the following stages:
i) se puso a disolver 2-bromometilnaftaleno en hexano a temperatura ambiente y,i) began to dissolve 2-bromomethylnaphthalene in hexane at temperature environment and,
ii) en atmósfera de nitrógeno, se añadió gota a gota una disolución de una cantidad estequiométrica de metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) a la disolución de (i) durante 10 min y se dejó reaccionar durante 16 horas a temperatura ambiente en agitación, yii) under a nitrogen atmosphere, was added drop by drop a solution of a stoichiometric amount of methacrylate 2- (N, N-dimethylamino) ethyl (DMAEMA) at solution of (i) for 10 min and allowed to react for 16 hours at room temperature under stirring, and
iii) se aisló un polvo blanco por filtración que se lavó con hexano, se secó a vacío hasta pesada constante y se caracterizó por resonancia magnética nuclear de protón y carbono. Rendimiento cuantitativo.iii) a white powder was isolated by filtration that washed with hexane, dried under vacuum until constant weighing and characterized by proton and carbon nuclear magnetic resonance. Quantitative performance
^{1}H-RMN (300 MHz, D_{2}O, 45ºC) \delta (ppm): 8.1-8.25 (m, 4H, Ar), 7.83 (t, 2H, J = 3.7 Hz, Ar), 7.72 (d, 1H, J = 8.4 Hz, Ar), 6.35 (s, 1H, COCH_{3}=CHaH), 5.98 (s, 1 H, OCOCH_{3}=CHbH), 4.84 (s, 2H, N^{+}CH_{2}), 4.80 (s, 2H, ArCH_{2}), 3.94 (t, 2H, J = 4.4 Hz, CO_{2}CH_{2}), 3.32 (s, 6H, NMe_{2}), 2.13 (s, 3H, OCOCH_{3}).1 H-NMR (300 MHz, D 2 O, 45 ° C) δ (ppm): 8.1-8.25 (m, 4H, Ar ), 7.83 (t, 2H, J = 3.7 Hz, Ar ), 7.72 (d, 1H, J = 8.4 Hz, Ar ), 6.35 (s, 1H, COCH 3 = C Ha H), 5.98 (s, 1 H, OCOCH 3 = C Hb H), 4.84 (s , 2H, N + C H 2 ), 4.80 (s, 2H, ArC H 2 ), 3.94 (t, 2H, J = 4.4 Hz, CO 2 C H 2 ), 3.32 (s, 6H, N Me_ {2}), 2.13 (s, 3H, OCOC H {3}).
^{13}C-RMN (75 MHz, D_{2}O, 45ºC) \delta (ppm): 168.9, 135.7, 134.2, 134.1, 133.2, 129.5, 129.0, 128.7, 128.3, 127.8, 124.8, 69.9, 63.2, 58.9, 51.1, 17.9.13 C-NMR (75 MHz, D 2 O, 45 ° C) δ (ppm): 168.9, 135.7, 134.2, 134.1, 133.2, 129.5, 129.0, 128.7, 128.3, 127.8, 124.8, 69.9, 63.2, 58.9, 51.1, 17.9.
Índice de refracción teórico, n_{D}^{20} = 1.577.Theoretical refractive index, n_ {D} 20 = 1,577.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Síntesis del bromuro de metacrilato de 2-(N-metilenantracenil,N,N-dimetilamonio)etilo (MON.ANTRAC): Synthesis of 2- (N-methylenanthracenyl, N, N-dimethylammonium) ethyl methacrylate bromide (MON.ANTRAC):
comprende las siguientes etapas:includes the following stages:
i) se puso a disolver metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) en diclorometano a 0ºC de temperatura,i) was dissolved to dissolve methacrylate of 2- (N, N-dimethylamino) ethyl (DMAEMA) in dichloromethane at 0 ° C temperature,
ii) en atmósfera de nitrógeno, se añadió gota a gota una disolución de una cantidad estequiométrica de 2-bromometilantraceno a la disolución de (i) durante 5 min y se dejó reaccionar durante 16 horas a temperatura ambiente en agitación, yii) under a nitrogen atmosphere, was added drop by drop a solution of a stoichiometric amount of 2-bromomethylantracene at the solution of (i) during 5 min and allowed to react for 16 hours at room temperature in agitation, and
iii) se aisló un polvo amarillento por filtración que se lavó con éter dietílico, se secó a vacío hasta pesada constante y se caracterizó por resonancia magnética nuclear de protón y carbono. Rendimiento, 86%.iii) a yellowish powder was isolated by filtration which was washed with diethyl ether, dried under vacuum until constant heavy and was characterized by nuclear magnetic resonance of proton and carbon. Yield 86%.
^{1}H-RMN (300 MHz, CDCl_{3}) \delta (ppm): 8.82 (d, 2H, J = 9.0 Hz, Ar), 8.43 (s, 1H, Ar), 7.89 (d, 2H, J = 8.3 Hz, Ar), 7.62 (t, 2H, J = 7.2 Hz, Ar), 7.4 (dd, 2H, J = 6.7, 8.3 Hz, Ar), 6.24 (s, 2H, ArCH_{2}), 6.05 (s, 1H, COCH_{3}=CHaH), 5.52 (t, J =1.27 Hz, 1H, OCOCH_{3}=CHbH), 4.67 (s, 4H, J = 2.3, N^{+}CH_{2}, CO_{2}CH_{2}), 3.22 (s, 6H, NMe_{2}), 1.81 (s, 3H, OCOCH_{3}).1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.82 (d, 2H, J = 9.0 Hz, Ar ), 8.43 (s, 1H, Ar ), 7.89 (d, 2H , J = 8.3 Hz, Ar ), 7.62 (t, 2H, J = 7.2 Hz, Ar ), 7.4 (dd, 2H, J = 6.7, 8.3 Hz, Ar ), 6.24 (s, 2H, ArC H2 ), 6.05 (s, 1H, COCH 3 = C Ha H), 5.52 (t, J = 1.27 Hz, 1H, OCOCH 3 = C Hb H), 4.67 (s, 4H, J = 2.3, N <+> C H 2 , CO 2 C H 2 ), 3.22 (s, 6H, N Me 2 ), 1.81 (s, 3H, OCOC H 3 ).
^{13}C-RMN (75 MHz, CDCl_{3}) \delta (ppm): 166.2, 134.9, 133.1, 132.2, 131.0, 129.2, 128.3, 127.3, 125.3, 124.7, 117.5, 63.8, 61.1, 58.3, 50.8, 18.2.13 C-NMR (75 MHz, CDCl 3) δ (ppm): 166.2, 134.9, 133.1, 132.2, 131.0, 129.2, 128.3, 127.3, 125.3, 124.7, 117.5, 63.8, 61.1, 58.3, 50.8, 18.2.
Índice de refracción teórico, n_{D}^{20} = 1.625.Theoretical refractive index, n_ {D} 20 = 1,625.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Síntesis del monómero bromuro de metacrilato
de 2-(N-metilenpirenil,N,N-
dimetilamonio)etilo (MON.PIRENI-
LO): Synthesis of 2- (N-methylene pirenil, N, N-dimethylammonium) ethyl methacrylate bromide monomer (MON.PIRENI-
THE):
comprende las siguientes etapas:includes the following stages:
i) se puso a disolver metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) en diclorometano a 0ºC de temperatura,i) was dissolved to dissolve methacrylate of 2- (N, N-dimethylamino) ethyl (DMAEMA) in dichloromethane at 0 ° C temperature,
ii) en atmósfera de nitrógeno, se añadió gota a gota una disolución de una cantidad estequiométrica de 2-bromometilpireno a la disolución de (i) durante 10 min y se dejó reaccionar durante 16 horas a temperatura ambiente en agitación, yii) under a nitrogen atmosphere, was added drop by drop a solution of a stoichiometric amount of 2-Bromomethylpyrene to the solution of (i) for 10 min and allowed to react for 16 hours at room temperature in agitation, and
iii) se aisló un polvo amarillento por filtración que se lavó con éter dietílico, se secó a vacío hasta pesada constante y se caracterizó por resonancia magnética nuclear de protón y carbono. Rendimiento, 89%.iii) a yellowish powder was isolated by filtration which was washed with diethyl ether, dried under vacuum until constant heavy and was characterized by nuclear magnetic resonance of proton and carbon. Yield 89%.
^{1}H-RMN (300 MHz, CDCl_{3}) \delta (ppm): 8.82 (d, 1H, J = 9.4 Hz, Ar), 8.30 (d, 1H, J = 7.9 Hz, Ar), 7.97-8.11 (m, 2H, Ar), 7.83-7.93 (m, 3H, Ar), 7.71 (d, 1H, J = 8.7 Hz, Ar), 7.60 (m, 1H, Ar), 6.05 (s, 2H, ArCH_{2}), 6.03 (s, 1H, COCH_{3}=CHaH), 5.50 (s, 1H, OCOCH_{3}=CHbH), 4.65 (s, 2H, N^{+}CH_{2}), 4.42 (s, 2H, CO_{2}CH_{2}), 3.39 (s, 6H, NMe_{2}), 1.80 (s, 3H, OCOCH_{3}).1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.82 (d, 1H, J = 9.4 Hz, Ar ), 8.30 (d, 1H, J = 7.9 Hz, Ar ), 7.97-8.11 (m, 2H, Ar ), 7.83-7.93 (m, 3H, Ar ), 7.71 (d, 1H, J = 8.7 Hz, Ar ), 7.60 (m, 1H, Ar ), 6.05 (s, 2H , ArC H 2 ), 6.03 (s, 1H, COCH 3 = C Ha H), 5.50 (s, 1H, OCOCH 3 = C Hb H), 4.65 (s, 2H, N + } C H 2 ), 4.42 (s, 2H, CO 2 C H 2 ), 3.39 (s, 6H, N Me 2 ), 1.80 (s, 3H, OCOC H 3 ) .
^{13}C-RMN (75 MHz, CDCl_{3}) \delta (ppm): 166.1, 135.4, 134.8, 134.2, 134.1, 132.6, 132.4, 131.8, 130.5, 130.3, 130.2, 129.9, 129.6, 128.8, 127.3, 126.6, 126.2, 126.0, 125.9, 124.2, 123.6, 123.3, 119.6, 66.0, 62.5, 58.1, 50.1, 18.1.13 C-NMR (75 MHz, CDCl 3) δ (ppm): 166.1, 135.4, 134.8, 134.2, 134.1, 132.6, 132.4, 131.8, 130.5, 130.3, 130.2, 129.9, 129.6, 128.8, 127.3, 126.6, 126.2, 126.0, 125.9, 124.2, 123.6, 123.3, 119.6, 66.0, 62.5, 58.1, 50.1, 18.1.
Índice de refracción teórico, n_{D}^{20} = 1.693.Theoretical refractive index, n_ {D} 20 = 1,693.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Síntesis del monómero bromuro de metacrilato
de
2-(N-acetofenil,N,N-dimetilamonio)etilo
(MON.ACETOFENI-
LO): Synthesis of 2- (N-acetophenyl, N, N-dimethylammonium) ethyl methacrylate bromide monomer (MON.ACETOFENI-
THE):
comprende las siguientes etapas:includes the following stages:
i) se puso a disolver 2-bromoacetofenona en hexano a temperatura ambiente,i) began to dissolve 2-Bromoacetophenone in hexane at temperature ambient,
ii) en atmósfera de nitrógeno, se añadió gota a gota una cantidad estequiométrica de metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) a la disolución de (i) y se dejó reaccionar durante 16 horas a temperatura ambiente en agitación, yii) under a nitrogen atmosphere, was added drop by drop a stoichiometric amount of methacrylate of 2- (N, N-dimethylamino) ethyl (DMAEMA) at solution of (i) and allowed to react for 16 hours at stirring room temperature, and
iii) se aisló un polvo blanco por filtración que se lavó con hexano, se secó a vacío hasta pesada constante y se caracterizó por resonancia magnética nuclear de protón y carbono. Rendimiento cuantitativo.iii) a white powder was isolated by filtration that washed with hexane, dried under vacuum until constant weighing and characterized by proton and carbon nuclear magnetic resonance. Quantitative performance
^{1}H-RMN (300 MHz, CDCl_{3}) \delta (ppm): 8.01 (dd, 2H, J = 7.16, 1.32 Hz, Ar), 7.56 (dt, 2H, J = 7.35, 1.18 Hz, Ar), 7.41 (dt, 1H, J = 8.1, 1.36 Hz, Ar), 5.87 (s, 2H, ArCH_{2}CO), 5.83 (s, 1H, COCH_{3}=CHaH), 5.35 (s, 1H, OCOCH_{3}=CHbH), 4.60 (t, 2H, J = 2.3, N^{+}CH_{2}), 4.41 (t, 2H, J = 2.3 Hz, CO_{2}CH_{2}), 3.72 (s, 6H, NMe_{2}), 1.71 (s, 3H, OCOCH_{3}).1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.01 (dd, 2H, J = 7.16, 1.32 Hz, Ar ), 7.56 (dt, 2H, J = 7.35, 1.18 Hz , Ar ), 7.41 (dt, 1H, J = 8.1, 1.36 Hz, Ar ), 5.87 (s, 2H, Ar CH2CO ), 5.83 (s, 1H, COCH3 = C Ha H), 5.35 (s, 1H, OCOCH 3 = C Hb H), 4.60 (t, 2H, J = 2.3, N + C H 2 ), 4.41 (t, 2H, J = 2.3 Hz, CO_ {2 C H 2 ), 3.72 (s, 6H, N Me 2 ), 1.71 (s, 3H, OCOC H 3 ).
^{13}C-RMN (75 MHz, CDCl_{3}) \delta (ppm): 190.9, 166.1, 134.8, 134.7, 133.9, 128.9, 128.4, 127.0, 66.8, 62.5, 58.1, 53.0, 17.9.13 C-NMR (75 MHz, CDCl 3) δ (ppm): 190.9, 166.1, 134.8, 134.7, 133.9, 128.9, 128.4, 127.0, 66.8, 62.5, 58.1, 53.0, 17.9.
Índice de refracción teórico, n_{D}^{20} = 1.521.Theoretical refractive index, n_ {D} 20 = 1,521.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Síntesis del monómero bromuro de metacrilato
de
2-(N-acetonaftil,N,N-dimetilamonio)etilo
(MON.ACETONAF-
TILO): Synthesis of 2- (N- acetone- ethyl, N, N-dimethylammonium) ethyl methacrylate bromide monomer (MON.ACETONAF-
LINDEN):
comprende las siguientes etapas:includes the following stages:
i) se puso a disolver 2-(bromoacetil) naftaleno en hexano a temperatura ambiente,i) began to dissolve 2- (bromoacetyl) naphthalene in hexane at room temperature,
ii) en atmósfera de nitrógeno, se añadió gota a gota una cantidad estequiométrica de metacrilato de 2-(N,N-dimetilamino)etilo (DMAEMA) a la disolución de (i) durante 10 min y se dejó reaccionar durante 16 horas a temperatura ambiente en agitación, yii) under a nitrogen atmosphere, was added drop by drop a stoichiometric amount of methacrylate of 2- (N, N-dimethylamino) ethyl (DMAEMA) at solution of (i) for 10 min and allowed to react for 16 hours at room temperature under stirring, and
iii) se aisló un polvo blanco por filtración que se lavó con hexano, se secó a vacío hasta pesada constante y se caracterizó por resonancia magnética nuclear de protón y carbono. Rendimiento cuantitativo.iii) a white powder was isolated by filtration that washed with hexane, dried under vacuum until constant weighing and characterized by proton and carbon nuclear magnetic resonance. Quantitative performance
^{1}H-RMN (300 MHz, CDCl_{3}) \delta (ppm): 8.84 (s, 1H, Ar), 7.93 (d, 1H, J = 8.1 Hz, Ar), 7.85 (dd, 1H, J = 1.37, 8.6 Hz, Ar), 7.71 (d, 2H, J = 8.8 Hz, Ar), 7.50 (dt, 1H, J = 1.1, 7.0 Hz, Ar), 7.39 (dt, 1H, J = 1.1, 7.0 Hz, Ar), 6.0 (s, 2H, 2H, ArCH_{2}CO), 5.79 (s, 1H, COCH_{3}=CHaH), 5.25 (s, 1H, OCOCH_{3}=CHbH), 4.60 (t, 2H, J = 2.3, N^{+}CH_{2}), 4.39 (t, 2H, J = 2.3 Hz, CO_{2}CH_{2}), 3.73 (s, 6H, NMe_{2}), 1.65 (s, 3H, OCOCH_{3}).1 H-NMR (300 MHz, CDCl 3) δ (ppm): 8.84 (s, 1H, Ar ), 7.93 (d, 1H, J = 8.1 Hz, Ar ), 7.85 (dd, 1H , J = 1.37, 8.6 Hz, Ar ), 7.71 (d, 2H, J = 8.8 Hz, Ar ), 7.50 (dt, 1H, J = 1.1, 7.0 Hz, Ar ), 7.39 (dt, 1H, J = 1.1 , 7.0 Hz, Ar ), 6.0 (s, 2H, 2H, Ar CH2CO ), 5.79 (s, 1H, COCH3 = C Ha H), 5.25 (s, 1H, OCOCH_3 = C Hb H), 4.60 (t, 2H, J = 2.3, N + C H 2 ), 4.39 (t, 2H, J = 2.3 Hz, CO 2 C H 2 ), 3.73 (s, 6H, N Me_ {2}), 1.65 (s, 3H, OCOC H {3}).
^{13}C-RMN (75 MHz, CDCl_{3}) \delta (ppm): 190.9, 166.1, 135.8, 134.6, 132.1, 131.5, 131.1, 130.0, 129.3, 128.6, 127.5, 127.0, 122.7, 66.8, 62.6, 58.1, 53.1, 17.9.13 C-NMR (75 MHz, CDCl 3) δ (ppm): 190.9, 166.1, 135.8, 134.6, 132.1, 131.5, 131.1, 130.0, 129.3, 128.6, 127.5, 127.0, 122.7, 66.8, 62.6, 58.1, 53.1, 17.9.
Índice de refracción teórico, n_{D}^{20} = 1.577.Theoretical refractive index, n_ {D} 20 = 1,577.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los monómeros de fórmula general (IV) se preparan mediante reacción del cloruro de metacriloilo con el alcohol del correspondiente benzotiazoliltio alquilo en presencia de trietilamina, según se describe en la patente estadounidense US7045558, para el monómero cuando n es igual a 2. Este procedimiento de obtención es extensible al resto de los monómeros que se recogen en la Fórmula (IV).The monomers of general formula (IV) are prepared by reacting methacryloyl chloride with the alcohol of the corresponding benzothiazolylthio alkyl in the presence of triethylamine, as described in US Pat. US7045558, for the monomer when n is equal to 2. This obtaining procedure is extensible to the rest of the monomers which are collected in Formula (IV).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Síntesis del metacrilato de 2-(benzotiazoliltio)etilo (MON.BENZOT): Synthesis of 2- (benzothiazolylthio) ethyl methacrylate (MON.BENZOT):
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
se sintetizó en dos etapas. La primera etapa comprende los siguientes pasos:It was synthesized in two stages. The first stage comprises the following Steps:
i) se puso a disolver 2-mercaptobenzotiazol (1 eq), KOH (1.5 eq) y Kl (0.5 eq) en una mezcla agua:etanol 1:1 a reflujoi) began to dissolve 2-mercaptobenzothiazole (1 eq), KOH (1.5 eq) and Kl (0.5 eq) in a mixture water: ethanol 1: 1 at reflux
ii) a esta mezcla se añadió cloroetanol (1.5 eq) y se dejó reaccionar durante 16 horas manteniendo el reflujo,ii) to this mixture was added chloroethanol (1.5 eq) and allowed to react for 16 hours while maintaining reflux,
iii) se aisló un polvo blanco por evaporación del etanol, extracción con diclorometano y purificación por cromatografía de gel de sílice con hexano:acetato de etilo (7:3) que se identificó como 2-(benzotiazoliltio) etanol por resonancia magnética nuclear de protón y carbono. Rendimiento, 90%.iii) a white powder was isolated by evaporation of ethanol, dichloromethane extraction and purification by silica gel chromatography with hexane: ethyl acetate (7: 3) which was identified as 2- (benzothiazolylthio) ethanol by resonance Proton and carbon nuclear magnetic. Yield 90%.
^{1}H-RMN (300 MHz, CDCl_{3}) \delta (ppm): 7.87 (dt, 1H, J = 0.47, 8.1 Hz, Ar), 7.76 (dt, 1H, J = 0.56, 7.9 Hz, Ar), 7.44 (dt, 1H, J = 1.27, 7.35 Hz, Ar), 7.33 (dt, 1H, J = 0.56, 7.35 Hz, Ar), 4.21 (s, 1H, OH), 4.09 (t, 2 H, J = 4.8 Hz, CH_{2}OH), 3.54 (t, 2H, J = 5.27 Hz, CH_{2}S).1 H-NMR (300 MHz, CDCl 3) δ (ppm): 7.87 (dt, 1H, J = 0.47, 8.1 Hz, Ar ), 7.76 (dt, 1H, J = 0.56, 7.9 Hz , Ar ), 7.44 (dt, 1H, J = 1.27, 7.35 Hz, Ar ), 7.33 (dt, 1H, J = 0.56, 7.35 Hz, Ar ), 4.21 (s, 1H, O H ), 4.09 (t, 2 H, J = 4.8 Hz, C H 2 OH), 3.54 (t, 2H, J = 5.27 Hz, C H 2 S).
^{13}C-RMN (75 MHz, CDCl_{3}) \delta (ppm): 167.8, 153, 135.8, 126.7, 125, 121.8, 121.5, 63, 37.13 C-NMR (75 MHz, CDCl 3) δ (ppm): 167.8, 153, 135.8, 126.7, 125, 121.8, 121.5, 63, 37.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La segunda etapa consistió en la obtención del éster metacrílico y comprende los siguientes pasos:The second stage consisted of obtaining the methacrylic ester and includes the following steps:
i) se puso a disolver 2-(benzotiazoliltio) etanol con Et_{3}N en diclorometano a 0ºC,i) began to dissolve 2- (benzothiazolylthio) ethanol with Et 3 N in dichloromethane at 0 ° C,
ii) en atmósfera de nitrógeno, se añadió gota a gota una cantidad estequiométrica de cloruro de metacriloilo a la disolución de (i) durante 30 min y se dejó reaccionar durante 3 horas a 0ºC de temperatura en agitación, yii) under a nitrogen atmosphere, was added drop by drop a stoichiometric amount of methacryloyl chloride to the solution of (i) for 30 min and allowed to react for 3 hours at 0 ° C stirring temperature, and
iii) se aisló un aceite transparente por extracción con diclorometano y se identificó como el metacrilato de 2-(benzotiazoliltio)etilo por resonancia magnética nuclear de protón y carbono. Rendimiento, 85%.iii) a clear oil was isolated by extraction with dichloromethane and was identified as methacrylate 2- (benzothiazolylthio) ethyl by nuclear magnetic resonance of proton and carbon Yield 85%.
^{1}H-RMN (300 MHz, CDCl_{3}) \delta (ppm): 7.85 (d, 1H, J = 8.1 Hz, Ar), 7.73 (d, 1H, J = 7.9 Hz, Ar), 7.40 (dt, 1H, J = 1.17, 7.30 Hz, Ar), 7.28 (dt, 1H, J = 1.08, 7.44 Hz, Ar), 6.11 (s, 1H, COCH_{3}=CHaH), 5.54 (q, 1H, J = 1.51 Hz, OCOCH_{3}=CHbH), 4.53 (t, 2H, J = 6.40 Hz, CH_{2}CO_{2}), 3.66 (t, 2H, J = 6.40 Hz, SCH_{2}), 1.92 (t, 3H, J = 1.04 Hz, OCOCH_{3}).1 H-NMR (300 MHz, CDCl 3) δ (ppm): 7.85 (d, 1H, J = 8.1 Hz, Ar ), 7.73 (d, 1H, J = 7.9 Hz, Ar ), 7.40 (dt, 1H, J = 1.17, 7.30 Hz, Ar ), 7.28 (dt, 1H, J = 1.08, 7.44 Hz, Ar ), 6.11 (s, 1H, COCH 3 = C Ha H), 5.54 ( q, 1H, J = 1.51 Hz, OCOCH 3 = C Hb H), 4.53 (t, 2H, J = 6.40 Hz, C H 2 CO 2), 3.66 (t, 2H, J = 6.40 Hz, SC H 2 ), 1.92 (t, 3H, J = 1.04 Hz, OCOC H 3 ).
^{13}C-RMN (75 MHz, CDCl_{3}) \delta (ppm): 166.9, 165.4, 152.9, 135.8, 135.2, 126.0, 129.5, 124.2, 121.5, 120.9, 62.7, 31.7, 18.1.13 C-NMR (75 MHz, CDCl 3) δ (ppm): 166.9, 165.4, 152.9, 135.8, 135.2, 126.0, 129.5, 124.2, 121.5, 120.9, 62.7, 31.7, 18.1.
Índice de refracción teórico, n_{D}^{20} = 1.623.Theoretical refractive index, n_ {D} 20 = 1,623.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se registran todos los espectros UV en diclorometano (10^{-4} M) en un espectrómetro Perkin Elmer UV/VIS Spectrometer Lambda 16. Se obtiene que los monómeros de antracenilo y naftilo absorben luz UV en el intervalo entre 220 y 300 nm y los monómeros de acetonaftilo y de benzotiazol en el intervalo entre 220 y 320 nm, lo que significa que estos cuatro monómeros pueden actuar como filtros de luz UV-B. El monómero de pirenilo presenta absorción en el intervalo entre 220 y 380 nm, cubriendo todo el intervalo de luz UV-A considerado como perjudicial para la retina, de manera que este monómero actúa como filtro de luz UV. Si este monómero se incorpora a la formulación de la LIO en la cantidad apropiada evitaría el tener que utilizar agentes de absorción UV adicionales. Los espectros UV de los monómeros citados se muestran en la figura 1.All UV spectra are recorded in dichloromethane (10-4M) on a Perkin Elmer UV / VIS spectrometer Spectrometer Lambda 16. It is obtained that anthracenyl monomers and naphthyl absorb UV light in the range between 220 and 300 nm and the acetone-ethyl and benzothiazole monomers in the range between 220 and 320 nm, which means that these four monomers can act as UV-B light filters. The pyrene monomer presents absorption in the range between 220 and 380 nm, covering the entire UV-A light range considered as harmful to the retina, so that this monomer acts as UV light filter If this monomer is incorporated into the formulation of IOL in the proper amount would avoid having to use additional UV absorption agents. The UV spectra of the cited monomers are shown in figure 1.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se prepararon sistemas copoliméricos en base a metacrilato de 2-hidroxietilo (HEMA), de fórmula:Copolymeric systems were prepared based on 2-hydroxyethyl methacrylate (HEMA), of formula:
y bromuro del metacrilato de 2-(N-bencil,N,N-dimetilamonio)etilo (MON.BENCILO) en presencia de uno o varios monómeros de voluminosote fórmula (III) tales como:and methacrylate bromide from 2- (N-benzyl, N, N-dimethylammonium) ethyl (MON.BENCILO) in the presence of one or more voluminosote monomers formula (III) such how:
- el metacrilato de 2-etoxietilo (EEMA), de fórmula:- 2-ethoxyethyl methacrylate (EEMA), of formula:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- metacrilato de 2-fenoxietilo (FEMA), de fórmula:- 2-phenoxyethyl methacrylate (FEMA), of formula:
- y metacrilato de bencilo (BMA), de fórmula:- and benzyl methacrylate (BMA), of formula:
a partir de las composiciones en la alimentación que se indican en la Tabla I. Los discos se obtienen por reacción de copolimerización de los monómeros en masa. Se vertieron las correspondientes mezclas de monómeros en moldes cilindricos de polipropileno y se añadió un 0.3%-p de azobisisobutironitrilo (AIBN) como iniciador radical. Se saturó el medio de reacción con nitrógeno y se cerró el molde con un tapón. Seguidamente se calentó a 70ºC durante 16 h. Una vez finalizado este tiempo se extrajeron las muestras que se sometieron a un post-curado a 70ºC durante 24 h. Finalmente, los discos se secaron a vacío hasta pesada constante. Con este procedimiento se obtuvieron discos de copolímero de 14.5 mm de diámetro y espesores comprendidos entre 0.5 y 4 mm dependiendo del volumen de reacción utilizado.from the compositions in the power indicated in Table I. The disks are obtained by copolymerization reaction of the monomers in bulk. Be poured the corresponding monomer mixtures into molds polypropylene cylinders and 0.3% -p of azobisisobutyronitrile (AIBN) as radical initiator. The reaction medium with nitrogen and the mold was closed with a plug. It was then heated at 70 ° C for 16 h. Once this is finished time the samples that were subjected to a post-cure at 70 ° C for 24 h. Finally, the discs were dried under vacuum until constant heavy. With this procedure 14.5 mm copolymer discs of diameter and thicknesses between 0.5 and 4 mm depending on the reaction volume used.
El grado de hidratación de estos sistemas se determinó utilizando una disolución de tampón borato de pH = 7.3 cuya composición se muestra en la Tabla II.The degree of hydration of these systems is determined using a borate buffer solution of pH = 7.3 whose composition is shown in Table II.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se sumergieron tres muestras de cada uno de los distintos sistemas preparados en la disolución tampón y se incubaron a 37ºC para simular las condiciones fisiológicas. Se extrajo la muestra a distintos tiempos, se secó su superficie cuidadosamente con papel de filtro y se pesó hasta alcanzar una pesada constante. A ese tiempo se calcula el porcentaje del grado de hidratación (H) mediante la ecuación siguiente.Three samples of each of the different systems prepared in the buffer solution and incubated at 37 ° C to simulate physiological conditions. The sample at different times, its surface was dried carefully with filter paper and weighed to a constant weight. TO that time the percentage of the degree of hydration is calculated (H) by the following equation.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
donde P_{H} es el peso de la muestra hidratada una vez alcanzado el equilibrio; P_{S} es el peso inicial de la muestra seca.where P H is the weight of the hydrated sample once equilibrium is reached; P_ {S} is the initial weight of the dry sample.
El índice de refracción de estos materiales se determinó con un refractómetro ABBE (ZEISS 133988) a una longitud de onda de 589 nm utilizando una lámpara de sodio, tanto en las muestras en estado seco como en las muestras hidratadas una vez alcanzado el equilibrio. Las medidas se hicieron a 20ºC (n_{D}^{20}).The refractive index of these materials is determined with an ABBE refractometer (ZEISS 133988) at a length of 589 nm wave using a sodium lamp, both in the dry samples as in hydrated samples once reached balance. The measurements were made at 20 ° C (n_ {20}).
La flexibilidad de los sistemas se estudió mediante determinación de la medida de la temperatura de transición vítrea (T_{g}) de los copolímeros en estado seco. Estas medidas se realizaron en un calorímetro diferencial de barrido (Perkin Elmer DSC7 conectado a un analizador TAC 7/DX). Para ello, se depositaron 15 mg de la muestra seca en el interior de una cápsula de aluminio sellada y se caliento a velocidad constante de 10ºC/min con un flujo de N_{2} de 50 ml/min en el intervalo de temperaturas de -10 a 200ºC. El calibrado de temperaturas del aparato se llevó a cabo con patrones de indio y zinc. La temperatura de transición vítrea (T_{g}) se tomó como el punto medio de la transición de la capacidad calorífica observada en el termograma correspondiente al segundo barrido. Se analizaron al menos dos muestras de cada composición.The flexibility of the systems was studied by determining the transition temperature measurement vitreous (T g) of the copolymers in the dry state. These measures are performed on a differential scanning calorimeter (Perkin Elmer DSC7 connected to a TAC 7 / DX analyzer). To do this, they deposited 15 mg of the dried sample inside an aluminum capsule sealed and heated at a constant speed of 10ºC / min with a flow of N2 of 50 ml / min in the temperature range of -10 to 200 ° C The temperature calibration of the device was carried out with indium and zinc patterns. Glass transition temperature (T_ {g}) was taken as the midpoint of the transition of the heat capacity observed on the thermogram corresponding to second sweep At least two samples from each were analyzed composition.
Los valores del porcentaje del grado de hidratación se muestran en la Tabla III junto con los valores de los índices de refracción tomados de la muestra seca e hidratada y de las temperaturas de transición vítreas.The percentage values of the degree of hydration are shown in Table III along with the values of the refractive indices taken from the dry and hydrated sample and from glass transition temperatures.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Las características de humectabilidad superficial de los materiales se evaluaron mediante medidas de ángulo de contacto en un goniómetro G10 (KRÜS) y utilizando el método de gota en reposo (Sessile Drop). Para ello se tomaron medidas del ángulo de contacto de un líquido polar (agua destilada, \gamma_{L} = 72.8 mJ/m^{2}) y de un líquido no polar (diiodometano, \gamma_{L} = 51.8 mJ/m^{2}) aplicando entre 8-10 gotas de 5 \mul de cada líquido sobre la superficie de cada muestra. La determinación de la tensión superficial se realizó aplicando el método de Owens (cfr. D. K. Owens, R. C. Wendt. J Appl Polym Sci 13, 1741-1747, 1969).The surface wettability characteristics of the materials were evaluated by contact angle measurements on a G10 goniometer (KRÜS) and using the resting drop method (Sessile Drop). For this purpose, the contact angle of a polar liquid (distilled water, γL = 72.8 mJ / m2) and a nonpolar liquid (diiodomethane, γL = 51.8 mJ /) were taken m2) applying between 8-10 drops of 5 µl of each liquid on the surface of each sample. The surface tension was determined using the Owens method (cf. DK Owens, RC Wendt. J Appl Polym Sci 13, 1741-1747, 1969).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se prepararon sistemas copoliméricos en base a
metacrilato de 2-hidroxietilo (HEMA), bromuro del
metacrilato de
2-(N-metilennaftil,N,N-dimetilamonio)etilo
(MON.NAFTILO) y metacrilato de 2-(benzotiazoliltio)etilo
(MON.BEN-
ZOT), en presencia de uno o varios monómeros de
fórmula (III) tales como el metacrilato de
2-etoxietilo (EEMA), metacrilato de
2-fenoxietilo (FEMA) o metacrilato de bencilo (BMA),
a partir de las composiciones en la alimentación que se muestran en
la Tabla V.Copolymeric systems based on 2-hydroxyethyl methacrylate (HEMA), 2- (N-methylene naphthyl, N, N-dimethylammonium) ethyl (MON.NAFTILO) methacrylate and 2- (benzothiazolylthio) ethyl methacrylate (MON .WELL-
ZOT), in the presence of one or more monomers of formula (III) such as 2-ethoxyethyl methacrylate (EEMA), 2-phenoxyethyl methacrylate (FEMA) or benzyl methacrylate (BMA), from the compositions in the power shown in Table V.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La reacción de copolimerización y purificación de los materiales obtenidos se realizaron según se describe en el Ejemplo 3. Igualmente, las determinaciones del grado de hidratación, índice de refracción de los materiales en estado seco e hidratado, temperatura de transición vítrea así como sus propiedades superficiales, se realizaron según los protocolos descritos en el Ejemplo 3. Los resultados obtenidos se recogen en las Tablas VI y VII.The copolymerization and purification reaction of the materials obtained were made as described in the Example 3. Similarly, the determinations of the degree of hydration, refractive index of dry and hydrated materials, glass transition temperature as well as its properties superficial, were performed according to the protocols described in the Example 3. The results obtained are shown in Tables VI and VII.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se prepararon sistemas copoliméricos en base a metacrilato de 2-hidroxietilo (HEMA) en presencia de uno o varios de los monómeros, bromuro del metacrilato de 2-(N-acetofenil,N,N-dimetilamonio)etilo (MON.ACETOFENILO), bromuro del metacrilato de 2-(N-acetonaftil,N,N-dimetilamonio)etilo (MON.ACETONAFTILO) y metacrilato de 2-(benzotiazoliltio)etilo (MON.BENZOT), y de uno o varios monómeros de fórmula (III) tales como el metacrilato de 2-etoxietilo (EEMA) o el metacrilato de 2-fenoxietilo (FEMA). Las composiciones en la alimentación de los sistemas preparados se indican en la Tabla VIII.Copolymeric systems were prepared based on 2-hydroxyethyl methacrylate (HEMA) in the presence of one or more of the monomers, methacrylate bromide 2- (N-acetophenyl, N, N-dimethylammonium) ethyl (MON.ACETOFENILO), methacrylate bromide 2- (N-acetonaphthyl, N, N-dimethylammonium) ethyl (MON.ACETONAFTILO) and 2- (benzothiazolylthio) ethyl methacrylate (MON.BENZOT), and of one or more monomers of formula (III) such such as 2-ethoxyethyl methacrylate (EEMA) or 2-phenoxyethyl methacrylate (FEMA). The compositions in the feed of the prepared systems are indicated in Table VIII.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La reacción de copolimerización y purificación de los materiales obtenidos se realizó según se describe en el Ejemplo 3. Igualmente las determinaciones del grado de hidratación así como el índice de refracción de los materiales en estado seco e hidratado se llevaron a cabo según los protocolos descritos en el Ejemplo 3. Los resultados obtenidos se recogen en la Tabla IX.The copolymerization and purification reaction of the materials obtained was performed as described in the Example 3. Equally the determinations of the degree of hydration as well as the index of refraction of materials in the dry state and hydrated were carried out according to the protocols described in the Example 3. The results obtained are shown in Table IX.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La actividad bactericida de los monómeros se determinó mediante el Método de Difusión sobre Agar descrito por Brauer y col. (cfr. A. W. Bauer, W. M. Kirby, J. C. Sherris, M. Turck. Am J Clin Pathol 45, 493-496, 1966) usando dos ensayos diferentes. Como cultivo modelo se usaron las cepas Staphylococcus epidermidis (RA 231) y Pseudomonas aeruginosa (B6). El cultivo se preservó almacenándolo a -80ºC en mezclas de glicerina/agua (20% v/v). Se prepararon disoluciones de cada monómero en concentración 2 M en agua para los bromuros de metacrilatos de n-alquilamonio y en DMSO para el metacrilato de benzotiazol. Agua y DMSO se usaron como blancos de la actividad bactericida. El medio de cultivo que fue caldo de corazón y cerebro, BHI, (Laboratorios Difco, USA). Todos los experimentos se realizaron por triplicado.The bactericidal activity of the monomers was determined by the Agar Diffusion Method described by Brauer et al. (cf. AW Bauer, WM Kirby, JC Sherris, M. Turck. Am J Clin Pathol 45, 493-496, 1966) using two different trials. The Staphylococcus epidermidis (RA 231) and Pseudomonas aeruginosa (B6) strains were used as a model culture. The culture was preserved by storing at -80 ° C in glycerin / water mixtures (20% v / v). Solutions of each monomer were prepared in 2M concentration in water for n-alkylammonium methacrylate bromides and in DMSO for benzothiazole methacrylate. Water and DMSO were used as targets of bactericidal activity. The culture medium that was heart and brain broth, BHI, (Laboratorios Difco, USA). All experiments were performed in triplicate.
En primer lugar se procedió al cultivo en 5 ml de medio BHI durante una noche entera a 37ºC, obteniéndose así un cultivo estacionario. Tras ese tiempo, mediante un colorímetro (Boecos-22 Spectrophotometer, Germany) se midió la absorbancia del cultivo estacionario a 600 nm. Para ajustar el valor del número de bacterias viables se determina el número de unidades formadoras de colonias de suspensiones (UCF) con distintas densidades ópticas, mediante técnicas estandarizadas de conteo sobre placas de medio-agar. Para determinar el número de UCF se prepararon diluciones 1/10, 1/100 y 1/1000 de los cultivos estacionarios. Se tomaron aproximadamente 1.5 ml de ellas y se añadieron sobre una mezcla en caliente de medio de cultivo-agar (2%) previamente esterilizado en autoclave. Antes de que la mezcla solidifique, cada mezcla de medio de cultivo-agar se extendió sobre tres placas Petri y se dejaron solidificar siempre en el interior de una cabina de flujo laminar para evitar contaminaciones.First, the culture was proceeded in 5 ml of BHI medium for a whole night at 37 ° C, thus obtaining a stationary culture After that time, using a colorimeter (Boecos-22 Spectrophotometer, Germany) the absorbance of stationary culture at 600 nm. To adjust the value from the number of viable bacteria the number of units is determined suspension colony forming (UCF) with different optical densities, using standardized counting techniques on half-agar plates. To determine the number of UCF 1/10, 1/100 and 1/1000 dilutions of the cultures were prepared stationary Approximately 1.5 ml of them were taken and added over a hot mixture of medium of agar culture (2%) previously sterilized in autoclave. Before the mixture solidifies, each mixture of medium of culture-agar spread on three Petri dishes and they were always solidified inside a cabin of laminar flow to avoid contamination.
Para el ensayo placa-pocillo se prepararon en primer lugar placas de agar con medio de cultivo conteniendo una concentración de la cepa bacteriana de 1.5 x 10^{8} unidades formadoras de colonias de suspensiones (UCF). Alícuotas de 1.5 ml del cultivo celular se mezclaron con 150 ml del correspondiente medio esterilizado y fundido, distribuido en placas Petri y se dejaron solidificar a temperatura ambiente. Se perforaron 6 pocillos en cada placa que se rellenaron con 40 \mul de las disoluciones de los monómeros. Todas las placas se incubaron a 37ºC durante 24 y 48 h. Para el ensayo de antibiogramas se prepararon placas de agar con medio de cultivo BHI según se describe arriba, pero sin la adición de la cepa bacteriana. Cuando las placas estuviron frías y el agar endurecido se extendió sobre la superficie de placas diferentes para cada cultivo, con la ayuda de una espátula estéril, las diluciones 1/10 de los cultivos preparados previamente. A continuación se depositaron sobre la superficie 6 discos especiales para antibiogramas (Schleicher & Schüll), empapados de las disoluciones a ensayar. Tras esto, las placas se cerraron y se cultivaron durante 24 y 48 h a 37ºC. La actividad inhibitoria de cada compuesto se determinó en función de la presencia de halo de inhibición en los alrededores de los pocillos o los discos que indican la ausencia de formación de colonias. Los resultados de este experimento se expresan como diámetro medio del halo en milímetros. El tamaño de los halos medidos a las 24 h para los diferentes monómeros incluyendo los 4 mm del pocillo y los 9 mm de los discos, se recogen en la Tabla X. A las 48 h de incubación se obtienen los mismos resultados. Se puede observar que todos los monómeros presentan actividad antimicrobiana frente al S. epidermidis y a P. aeruginosa, sin embargo los monómeros de bromuros de metacrilatos de n-alquilamonio presentan una actividad notablemente superior a la del monómero portador del grupo azol. Dentro de los bromuros de metacrilatos de n-alquilamonio, los derivados de naftilo y acetofenilo presentan una actividad ligeramente mayor frente a P. aeruginosa en comparación con la del monómero de bencilo. Además se observa una buena correlación en los resultados obtenidos en ambos tipos de ensayos. En el ensayo placa-pocillo los bromuros de metacrilato de n-alquilamonio producen doble halo de inhibición.For the plate-well test , agar plates with culture medium containing a concentration of the bacterial strain of 1.5 x 10 8 suspension colony forming units (UCF) were first prepared. 1.5 ml aliquots of the cell culture were mixed with 150 ml of the corresponding sterilized and molten medium, distributed in Petri dishes and allowed to solidify at room temperature. 6 wells were drilled in each plate which were filled with 40 µl of the monomer solutions. All plates were incubated at 37 ° C for 24 and 48 h. For the antibiogram assay agar plates were prepared with BHI culture medium as described above, but without the addition of the bacterial strain. When the plates were cold and the hardened agar was spread on the surface of different plates for each crop, with the help of a sterile spatula, 1/10 dilutions of the previously prepared cultures. Subsequently, 6 special disks for antibiograms (Schleicher & Schüll), soaked with the solutions to be tested, were deposited on the surface. After this, the plates were closed and grown for 24 and 48 h at 37 ° C. The inhibitory activity of each compound was determined based on the presence of inhibition halo in the vicinity of the wells or discs that indicate the absence of colony formation. The results of this experiment are expressed as mean diameter of the halo in millimeters. The size of the halos measured at 24 h for the different monomers including the 4 mm of the well and the 9 mm of the discs, are collected in Table X. At 48 h of incubation the same results are obtained. It can be seen that all monomers have antimicrobial activity against S. epidermidis and P. aeruginosa , however the monomers of n-alkylammonium methacrylate bromides have a markedly higher activity than the monol carrier monomer. Within n-alkylammonium methacrylate bromides, naphthyl and acetophenyl derivatives have a slightly higher activity against P. aeruginosa compared to that of benzyl monomer. In addition, a good correlation is observed in the results obtained in both types of trials. In the plate-well test, n-alkylammonium methacrylate bromides produce double inhibition halo.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La citotoxicidad proveniente de cualquier extracto de los materiales se analizó mediante cultivos celulares utilizando el ensayo MTT. Para este ensayo se utilizaron fibroblastos humanos (FBH) cultivados a 37ºC. El medio de cultivo fue Dulbecco's Modified Eagle's Medium Eagle (MEM) modificado con HEPES y enriquecido con 10% de suero fetal bovino (FBS), 200 mM de L-glutamina, 100 unidades/ml de penicilina y 100 \mug/ml de estreptomicina. El medio de cultivo se cambió a intervalos de tiempo seleccionados. Como control negativo del ensayo se utiliza Thermanox® (TMX), como control positivo del ensayo se utiliza una disolución al 1% v/v de Tritón X-100 (TRITÓN) y como control de los materiales desarrollados para LIOs se ensayan discos de HEMA-EEMA 80:20, que es la composición de la lente comercial de AJL Ophthalmics. La relación de materiales ensayados se muestra en la Tabla XI.The cytotoxicity from any extract of the materials was analyzed by cell cultures using the MTT assay. For this test, human fibroblasts (FBH) grown at 37 ° C were used. The culture medium was Dulbecco's Modified Eagle's Medium Eagle (MEM) modified with HEPES and enriched with 10% fetal bovine serum (FBS), 200 mM L-glutamine, 100 units / ml penicillin and 100 µg / ml streptomycin . The culture medium was changed at selected time intervals. As a negative control of the test, Thermanox® (TMX) is used, a 1% v / v solution of Triton X-100 (TRITON) is used as a positive control of the test and HEMA disks are tested as a control of the materials developed for IOLs -EEMA 80:20, which is the composition of the commercial lens of AJL Ophthalmics. The ratio of materials tested is shown in Table XI.
Discos de 10 mm de diámetro y 1 mm de espesor de los materiales a ensayar y de Thermanox® (TMX) se sumergieron en 5 ml de MEM. A continuación se introdujeron en una estufa a 37ºC, se extrajo el medio a diferentes tiempos (6 h, 1, 2, 3 y 7 días) y se reemplazó con otros 5 ml de medio fresco. Todos los extractos se obtuvieron bajo condiciones estériles. Los fibroblastos se sembraron a una densidad de 8 x 10^{4} células/ml en medio completo en una placa de cultivos estéril de 96 pocillos y se incubaron a confluencia. Entonces, el medio se reemplazó con los correspondientes extractos eluídos de las muestras, con los exudados del TMX y por una disolución al 1% v/v de tritón X-100 en medio de cultivo. Las placas se incubaron a 37ºC en atmósfera de aire humidificada con 5% CO_{2} durante 24 horas. Se preparó una disolución de MTT, 5 mg/ml en una disolución de tampón fosfato (PBS) templada y se filtró antes de usarse, obteniendo la disolución madre. Ésta, a su vez, fue diluida al 10% en medio fresco, obteniendo la disolución de trabajo. Se añadieron 100 \mul de esta disolución a cada uno de los pocillos para dar una concentración final de 0.5 mg/ml, y las placas se incubaron a 37ºC durante 4 h. Se extrajo el contenido de los pocillos y se añadieron 100 \mul de dimetilsulfóxido (DMSO) a todos los pocillos con el fin de disolver el MTT tomado por las células. Después de una agitación de 20s a elevada intensidad, se midió la absorbancia con un lector de placas Biotek ELX808IU usando una longitud de onda del ensayo 570 nm y una longitud de onda de referencia de 630 nm. Los resultados se normalizaron con respecto al Thermanox® (TMX = 100%) y se realizó el estudio estadístico del análisis de la varianza (ANOVA) de los mismos con respecto al TMX y con respecto al material HEMA-EEMA (p<0.05). Los resultados del ensayo se muestran en la Figura 2. Se puede observar que los lixiviados de todos los materiales para LIOs no producen efectos tóxicos en el medio, permitiendo que la viabilidad celular de los cultivos realizados en su presencia alcance valores cercanos al 100% en todos los casos.10 mm diameter and 1 mm thick discs of the materials to be tested and Thermanox® (TMX) were submerged in 5 ml of MEM. They were then placed in an oven at 37 ° C, He extracted the medium at different times (6 h, 1, 2, 3 and 7 days) and replaced with another 5 ml of fresh medium. All extracts are obtained under sterile conditions. The fibroblasts were seeded at a density of 8 x 10 4 cells / ml in complete medium in a 96-well sterile culture plate and incubated at confluence. Then, the medium was replaced with the corresponding eluted extracts from the samples, with exudates of TMX and by a 1% v / v solution of triton X-100 in culture medium. The plates were incubated at 37 ° C in a humidified air atmosphere with 5% CO2 for 24 hours. A solution of MTT, 5 mg / ml in a solution was prepared of phosphate buffer (PBS) tempered and filtered before use, obtaining the mother solution. This, in turn, was diluted to 10% in fresh medium, obtaining the working solution. They were added 100 µl of this solution to each of the wells to give a final concentration of 0.5 mg / ml, and the plates were incubated at 37 ° C for 4 h. The contents of the wells were extracted and added 100 µL of dimethylsulfoxide (DMSO) to all wells in order to dissolve the MTT taken by the cells. after one 20s stirring at high intensity, absorbance was measured with a Biotek ELX808IU plate reader using a wavelength of 570 nm test and a reference wavelength of 630 nm. The results were normalized with respect to Thermanox® (TMX = 100%) and the statistical study of the analysis of variance was carried out (ANOVA) of them with respect to the TMX and with respect to the material HEMA-EEMA (p <0.05). The test results are shown in Figure 2. It can be seen that leachate from All materials for IOLs do not produce toxic effects on the medium, allowing the cell viability of the cultures made in your presence reach values close to 100% in all the cases.
Claims (29)
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- n es un valor de 1 a 12;n is a value of 1 to 12;
- X es un anión que se selecciona del grupo que comprende un halógeno o un sulfonato,X is an anion which is selected from the group comprising a halogen or a sulfonate,
- R_{1} es un hidrógeno o un grupo metilo;R_ {1} is a hydrogen or a methyl group;
- R_{2} y R_{3} son iguales o diferentes entre sí, y representan un radical alquilo (C_{1}-C_{3}).R2 and R 3 are the same or different from each other, and represent a radical (C 1 -C 3) alkyl.
- R_{4} es un radical arilo, sustituido o no sustituido, o un radical acetilo, sustituido o no sustituido.R_ {4} is a aryl radical, substituted or unsubstituted, or an acetyl radical, substituted or unsubstituted.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- n es de 0 a 4,n is from 0 to 4,
- m es de 0 a 1; ym is from 0 to 1; Y
- R_{1} es un hidrógeno o un grupo metilo.R_ {1} is a hydrogen or a methyl group.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- n es 1 ó 2,n is 1 or 2,
- R_{1} es un hidrógeno o un grupo metilo; yR_ {1} is a hydrogen or a methyl group; Y
- R_{2} se selecciona de la lista que comprende un hidrógeno, un alquilo (C_{1}-C_{6}) o un alcoxilo o un arilo.R2 is select from the list comprising a hydrogen, an alkyl (C 1 -C 6) or an alkoxy or an aryl.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- n es de 1 a 6.n is from 1 to 6.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- i) i)
- se mezclan los monómeros de fórmula general (I) con los monómeros de fórmula general (II) en presencia de un iniciador de polimerización radical,the monomers of general formula (I) are mixed with the monomers of general formula (II) in the presence of an initiator of radical polymerization,
- ii) ii)
- se desoxigena la mezcla de reacción del paso (i),the reaction mixture of the step is deoxygenated (i),
- iii) iii)
- se somete, la mezcla obtenida en el paso (ii), a tratamiento térmico a una temperatura de entre 45ºC y 70ºC, durante el tiempo necesario hasta alcanzar la conversión total,The mixture obtained in step (ii) is subjected to heat treatment at a temperature between 45ºC and 70ºC, during the time necessary to reach the total conversion,
- iv) iv)
- posteriormente el material del paso (iii) se somete a un post-curado a una temperatura de entre 60ºC y 80ºC durante un tiempo de entre 24 y 96 h.subsequently the material of step (iii) is submitted at a post-cure at a temperature between 60 ° C and 80 ° C for a time between 24 and 96 h.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200900828A ES2345595B1 (en) | 2009-03-26 | 2009-03-26 | HYDROPHILE ACRYLIC SYSTEMS OF ELEVATE REFRACTION INDEX FOR PREPARATION OF INTRAOCULAR LENSES. |
| PCT/ES2010/070137 WO2010109043A1 (en) | 2009-03-26 | 2010-03-09 | Hydrophilic acrylic systems with a high refractive index for producing intraocular lenses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200900828A ES2345595B1 (en) | 2009-03-26 | 2009-03-26 | HYDROPHILE ACRYLIC SYSTEMS OF ELEVATE REFRACTION INDEX FOR PREPARATION OF INTRAOCULAR LENSES. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2345595A1 ES2345595A1 (en) | 2010-09-27 |
| ES2345595B1 true ES2345595B1 (en) | 2011-07-21 |
Family
ID=42727326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200900828A Expired - Fee Related ES2345595B1 (en) | 2009-03-26 | 2009-03-26 | HYDROPHILE ACRYLIC SYSTEMS OF ELEVATE REFRACTION INDEX FOR PREPARATION OF INTRAOCULAR LENSES. |
Country Status (2)
| Country | Link |
|---|---|
| ES (1) | ES2345595B1 (en) |
| WO (1) | WO2010109043A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015159942A1 (en) * | 2014-04-17 | 2015-10-22 | 株式会社シード | Medical device including anionic drug |
| JP6158754B2 (en) * | 2014-06-04 | 2017-07-05 | 信越化学工業株式会社 | Resist underlayer film forming composition and pattern forming method |
| KR102242548B1 (en) | 2017-11-14 | 2021-04-20 | 주식회사 엘지화학 | Photoresist composition |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4218554A (en) * | 1978-10-11 | 1980-08-19 | Foley William M Jr | Process for preparing hydrogel contact lenses containing quaternary ammonium salts |
| US5693095A (en) * | 1995-06-07 | 1997-12-02 | Alcon Laboratories, Inc. | High refractive index ophthalmic lens materials |
| US20020037984A1 (en) * | 1998-12-11 | 2002-03-28 | Vanderbilt David P. | High refractive index hydrogel compositions for ophthalmic implants |
| WO2008101806A2 (en) * | 2007-02-20 | 2008-08-28 | Basf Se | High refractive index monomers, compositions and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW228529B (en) * | 1992-12-23 | 1994-08-21 | Ciba Geigy |
-
2009
- 2009-03-26 ES ES200900828A patent/ES2345595B1/en not_active Expired - Fee Related
-
2010
- 2010-03-09 WO PCT/ES2010/070137 patent/WO2010109043A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4218554A (en) * | 1978-10-11 | 1980-08-19 | Foley William M Jr | Process for preparing hydrogel contact lenses containing quaternary ammonium salts |
| US5693095A (en) * | 1995-06-07 | 1997-12-02 | Alcon Laboratories, Inc. | High refractive index ophthalmic lens materials |
| US20020037984A1 (en) * | 1998-12-11 | 2002-03-28 | Vanderbilt David P. | High refractive index hydrogel compositions for ophthalmic implants |
| WO2008101806A2 (en) * | 2007-02-20 | 2008-08-28 | Basf Se | High refractive index monomers, compositions and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010109043A1 (en) | 2010-09-30 |
| ES2345595A1 (en) | 2010-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020270475B2 (en) | Polymerizable fused tricyclic compounds as absorbers of UV and visible light | |
| JP6131442B2 (en) | Polymerizable material | |
| ES2885148T3 (en) | Compounds for optically active devices | |
| ES2850898T3 (en) | Hydrophobic Compounds for Optically Active Devices | |
| US11702396B2 (en) | Hydrophobic compounds for optically active devices | |
| ES2523387T3 (en) | Materials for high refractive index acrylic ophthalmic devices with reduced reflections | |
| JP2025138734A (en) | Polymerizable absorbers of UV and high energy visible light | |
| TWI593994B (en) | Medical device with uniform charge density and method for manufacturing same | |
| AU2020270475A1 (en) | Polymerizable fused tricyclic compounds as absorbers of UV and visible light | |
| JP2002532588A (en) | Crosslinked polymers and refractive devices formed therefrom | |
| ES2927417T3 (en) | Amphiphilic Antimicrobial Hydrogel | |
| ES2345595B1 (en) | HYDROPHILE ACRYLIC SYSTEMS OF ELEVATE REFRACTION INDEX FOR PREPARATION OF INTRAOCULAR LENSES. | |
| US8980956B2 (en) | Methods for producing biocompatible materials | |
| US20200002363A1 (en) | Compounds containing si atoms for optically active devices | |
| CN101595419B (en) | Hydrogel contact lens comprising a polymer comprising a carboxy betaine ester monomer | |
| EP2581394A1 (en) | Ionic compound, composition, cured product, hydrogel, and ocular lens | |
| Parra et al. | Foldable antibacterial acrylic intraocular lenses of high refractive index | |
| KR101553685B1 (en) | Antibacterial hydrogel contact lens and method for manufacturing the same | |
| US20150353667A1 (en) | Flexible, high refractive index hydrophobic copolymer | |
| ES2340241B1 (en) | HYDROPHILE ACRYLIC COPOLYMERS DERIVED FROM EUGENOL, PREPARATION, CHARACTERIZATION AND ITS USE AS OPHTHALMIC LENSES. | |
| RU2795094C2 (en) | Polymerizable condensed tricyclic compounds as uv and visible light absorbers | |
| ES2359186T3 (en) | IMPROVED SYNTHESIS OF CATIONIC SILOXANO PREPOLYMERS. | |
| HK1229267B (en) | (meth)acrylamide polymers for contact lens and intraocular lens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20100927 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2345595 Country of ref document: ES Kind code of ref document: B1 Effective date: 20110721 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20180924 |